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ABSTRACT 
 
Jonathan Ciencewicki: Effect of Diesel Exhaust on the Host Response to Respiratory Viral 
Infection: Involvement of Toll-like Receptor 3 
(Under the direction of Dr. Ilona Jaspers) 
 
 Adverse effects resulting from exposure to air pollutants have become an increasing 
problem worldwide. Particularly levels of air pollutants have been associated with increases 
in the susceptibility and response to many respiratory diseases. Of the numerous air 
pollutants, diesel exhaust (DE) has become a major concern since it can account for a 
significant amount of the pollutants generated by motor vehicles in many areas. Previous 
results in our laboratory have demonstrated that prior exposure of respiratory epithelial cells 
to DE enhances the susceptibility to influenza infections. In this work, these results were 
confirmed and expanded upon both in vitro and in vivo. The effects of DE on the expression 
and signaling of toll-like receptor 3 (TLR3), which has previously shown to be needed for a 
complete innate immune response to influenza infections as well as other respiratory viral 
infections, were examined as well as mechanistic aspects involved in the observed effects. 
Increased expression and signaling of TLR3 was observed in respiratory epithelial cells 
exposed to DE prior to infection with influenza, resulting in an enhancement of the 
influenza-induced inflammatory and interferon (IFN) responses. A positive-feedback loop 
involving type I IFNs and DE-induced effects on epithelial cell tight junctional complexes 
played a role in the observed effects. In vivo exposure of mice to DE enhanced the 
susceptibility to influenza infections and decreased expression of surfactant proteins A and 
D, which are an important part of the innate immune defense against influenza and other 
 iii
respiratory viruses. Together, these results demonstrate that exposure to an oxidant air 
pollutant, such as diesel exhaust, can enhance the susceptibility and response to respiratory 
viral infection and elucidate potential mechanisms behind some of these effects.  
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Chapter 1 
 
Introduction 
  Air pollution has become an increasing concern in many areas worldwide. Despite 
current regulations, which limit the levels of certain air pollutants, there are still a number of 
adverse health effects that result from exposure to these agents. Numerous epidemiological 
studies have noted an association between the levels of air pollution and hospital admissions 
for a variety of different health reasons, including various respiratory diseases, such as 
asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections (6, 48, 58, 
106, 211, 251). In addition to an increase in hospital admissions, studies have also noted an 
association between the levels of air pollution and mortality (4, 12, 17, 45, 96, 168, 182, 
186). Together these studies provide compelling evidence that the health risks from exposure 
to ambient air pollution are serious, especially for susceptible populations such as children 
and the elderly (58, 96, 182,  211).  
“Criteria” Air Pollutants 
 The United States Environmental Protection Agency (U.S. EPA) is required by the Clean 
Air Act to set National Ambient Air Quality Standards (NAAQS) for certain pollutants, 
which are considered to be harmful to human health and the environment. The six “criteria” 
pollutants, for which there are NAAQS regulated by the U.S. EPA  are carbon monoxide 
(CO), lead (Pb), nitrogen dioxide (NO2), particulate matter (PM), ozone (O3), and sulfur 
dioxide (SO2) (232). Epidemiological studies have noted associations between the levels of 
many of these pollutants and hospital admissions for respiratory causes (58, 136, 211, 219) as 
well as increased respiratory morbidity and mortality (12, 61, 168, 182, 185, 186). 
Additionally, levels of some of these pollutants have also been associated with decrements in 
lung function and exacerbations of allergic diseases, such as asthma (59, 136, 140, 216, 219, 
231). Furthermore, experimental studies have shown that exposure to pollutants causes an 
inflammatory response in the lungs (139, 142, 164, 188).  
 In addition to the effects mentioned above, exposure to several of these pollutants has 
also been shown to enhance the susceptibility or alter the response to respiratory viral 
infections. Epidemiological evidence has demonstrated that increased levels of certain air 
pollutants are associated with the incidence of and hospital admissions for chronic cough, 
bronchitis, croup, pneumonia, influenza, as well as other upper respiratory infections (46, 58, 
211, 252). Experimental studies examining the effects of air pollutant exposure on the 
susceptibility and response to viral infection have shown that exposure to air pollutants can 
increase the susceptibility to infection, enhance the morbidity, including an increased 
inflammatory response, associated with infection, as well as decrease macrophage function 
(54, 83, 176, 210). Together these data provide evidence of the broad range of effects 
induced by exposure to air pollutants.  
Diesel Exhaust 
 A particular air pollutant that has become a concern is diesel exhaust (DE), since it can 
account for a significant percentage of air pollutants generated by motor vehicles in many 
places (42, 234, 235) and epidemiological data and experimental studies suggest that DE is a 
major contributor to adverse health effects associated with exposure to particulate air 
pollutants (235, 249). Diesel engines are widely used for land and sea transport, electrical 
power, farming, and construction, due to their fuel efficiency and durability. In fact, at full 
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load diesel engines use about 70% of the amount of fuel that a gasoline engine would 
consume under the same conditions, and at partial loads the advantage is even greater (52, 
220). However, PM emissions from diesel engines are relatively high compared with those 
from gas engines (34, 248). A majority of the diesel PM and NOx emissions are produced by 
off-road and heavy-duty on-road vehicles (233) and studies from California have shown that 
while on-road diesel vehicles contribute about 5% of daily vehicle miles traveled they are 
responsible for about 35% and 56% of the NOx and PM produced by vehicle emissions, 
respectively (23). Ambient DE particle (DEP) concentrations range from ~5-50 µg/m3, 
whereas occupational concentrations, such as mechanics, truck drivers, or bus garages, have 
been shown to be anywhere from ~25-200µg/m3 and even as high as 1-2 mg/m3 in some 
mining occupations.  Furthermore, off-road diesel engines emit about 2 times the amount of 
PM as on-road vehicles, making them a serious concern for PM-induced health effects (23) 
 DE contains both particulate phase as well as gas phase components such as CO, SO2, 
NOx, hydrocarbons, transition metals, and formaldehyde (194). The exact composition 
depends on operating conditions such as speed, load, fuel, engine and vehicle type, air 
temperature, and humidity. DEPs consist of a carbon core with many organic compounds 
adsorbed onto them. Due to their small mass median diameter (0.05-1.0µm), DE particles are 
easily respirable and capable of being deposited in the lower airways and alveoli to a greater 
extent than larger particles (32, 209). It has been estimated that at least 80% of freshly 
emitted DEPs are ≤ 0.1µm, which translates into a much greater surface to volume ratio 
(184). Therefore, a given mass of DEPs has, more particles, a larger surface area to adsorb 
compounds onto their surface, and can affect a greater surface area of lung tissue, than the 
equivalent mass of larger particles (151). Additionally, DEPs have the potential to travel 
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greater distances than those generated by gasoline engines, allowing them to disseminate 
over a much broader area (145).  
There is abundant epidemiological and experimental evidence indicating that exposure to 
DE can cause adverse health effects, particularly in occupational exposures and susceptible 
populations. Studies have shown associations between levels of PM, of which DEPs can be a 
significant contributor, and cardiopulmonary mortality (47, 96, 168, 185). Other studies have 
shown an association between exposure to ambient PM and hospital admissions for cardiac 
and respiratory causes (4, 6, 106, 136, 219). There are a number of chemicals in DE known 
as human carcinogens and the National Institute of Occupational Safety and Health (NIOSH) 
recommends that DE be regarded as a potential carcinogen. Epidemiological evidence has 
noted an association between long-term occupational exposure to DE and increased risk for 
lung cancer (24, 119). In addition, both in vitro and in vivo studies have shown that exposure 
to DE or DEPs results in increased pulmonary inflammation and the production of reactive 
oxygen species (9, 43, 150, 179, 180,  215). Taken together, this evidence shows a wide 
range of adverse health effects caused by exposure to DE.  
Diesel Exhaust and Respiratory Viral Infections 
 DE has also been implicated in having adverse effects on host immunity. It has been 
shown that DE increases cellular responsiveness to histamine (75, 100) and acts as an 
adjuvant to IgE production in human nasal exposures and murine models (44, 55, 143, 149). 
In addition, epidemiological evidence has noted an association between ambient particulate 
matter and pulmonary infections (166), including exacerbation of respiratory symptoms 
associated with these infections (30, 58, 155). Exposure to DE can also enhance the 
susceptibility to respiratory viral infections. The first study to examine the effects of chronic 
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DE exposure on the susceptibility to respiratory viral infection was conducted by Hahon et 
al. (69). Mice were exposed to 2mg/m3 of diesel exhaust for 1, 3, or 6 months followed by 
infection with influenza virus. Higher virus growth levels and decreased interferon levels 
were observed in mice exposed to DE for 3 and 6 months compared to air-exposed mice. 
Additionally, antibodies against hemagglutinin, an influenza-associated protein, were lower 
in these mice. Another study examined the effect of short-term DE exposure on the 
susceptibility and response to RSV infection in mice (71). Mice were exposed to 300µg/m3 or 
1,000µg/m3 of DE for 6 hours/day for seven consecutive days followed by infection with 
RSV. DE-exposed mice were more susceptible to RSV infection, shown by an increase in 
RSV gene expression in the lungs of mice exposed to either dose of DE compared to air 
controls. Prior exposure to DE also caused an enhancement of the inflammatory response to 
RSV infection.  Additionally, studies in our laboratory have shown that exposure of human 
respiratory epithelial to DE enhances the susceptibility to influenza infections (85). Together, 
these studies demonstrate that exposure to DE enhances the susceptibility and response to 
respiratory viral infections, and may result in an increase of the resulting morbidity of 
infection. However, the mechanism(s) whereby exposure to DE modulates the host response 
to respiratory virus infections is not yet clear.  
Influenza 
 Influenza infections in the U.S. account for approximately 36,000 deaths and over 
100,000 hospitalizations each year, despite large-scale vaccination and antiviral treatments 
(226, 227). Influenza is a single-stranded, segmented RNA virus that is a member of the 
orthomyxoviridae family. The virus is classified as Influenza A, B, and C, with Influenza A 
being the most pathogenic. Influenza A consists of eight RNA segments that encode for 10 
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viral proteins: hemagglutinin (HA), neuramindase (NA), nucleoprotein (NP), matrix protein 
(M1), 3 polymerase proteins, an ion channel protein, and 2 nonstructural proteins. The outer 
part of the virus consists of a lipid bilayer coated with protein “spikes” which are HA and 
NA. These two proteins are the common epitopes for host antibody recognition. Influenza A 
usually binds to and infects epithelial cells of the respiratory tract, but can also infect 
monocytes/macrophages and leukocytes.  The virus binds to sialic acid-containing receptors 
on the host cell through it’s HA molecules. Once the virus has attached to the cell it gains 
entry through clathrin-dependent endocytosis. Recent studies have also shown that influenza 
can enter the cell by other endocytic pathways as well (204). Infected cells respond to 
Influenza by releasing chemokines and cytokines. Epithelial cells commonly produce 
RANTES, IL-6, IL-8, and MCP-1 to recruit and activate inflammatory cells as well as type I 
interferons (IFN-α and IFN-β), which activate anti-viral responses within the cell.   
Innate Immune Response to Influenza Infection 
The host’s first line of defense against invading pathogens is the innate immune response.  
It keeps the infection under control until the adaptive immune response is mobilized.  Many 
of the cytokines released upon infection have pleiotropic effects, but for the purpose of this 
review only their actions in response to viral infection will be discussed. IL-6 is a potent 
pyrogen that activates T cells and stimulates Ig production in B cells. IL-8 is a neutrophil 
attractant, MCP-1 recruits monocytes, and RANTES attracts T lymphocytes and monocytes. 
Neutrophils and macrophages recruited to the site of infection mediate an inflammatory 
response and phagocytose virus and dead or dying cells. Secreted type I interferons activate 
macrophages and NK cell function and enhance antigen presentation through upregulation of 
MHC expression and stimulation of maturation of antigen presenting cells. This important 
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antiviral cytokine also induces the expression of a number of genes involved in inhibiting 
viral replication. The type I IFN system plays a critical role in the innate immune response to 
viral infection and will be discussed in further detail later on. IL-18, another cytokine 
produced in response to influenza infection, has pro-inflammatory properties and also 
activates NK and T cell IFN-γ production. IFN-γ also activates NK cells and macrophages, 
and functions in the long-term control of viral infections. Recently another group of IFN-like 
cytokines were identified and termed IL-28 and IL-29. These cytokines are induced upon 
viral infection and display antiviral properties (203). Many of the cytokines and chemokines 
mentioned thus far are the end result of signaling cascades elicited by pattern recognition 
receptors (PRRs), which recognize molecular patterns associated with the influenza virus. 
The PRRs that are thought to play a role in the innate immune response to influenza infection 
are toll-like receptor 3 (TLR3), retinoic acid-inducible protein I (RIG-I), and eukaryotic 
translation initiation factor 2-alpha kinase 2 (PKR).  
Another important part of the host’s innate immune defense against influenza are the 
surfactant proteins (SP). These hydrophilic proteins, SP-A and SP-D, are secreted by alveolar 
type II cells and clara cells in the lung and facilitate phagocytosis, as well as regulate 
inflammation (124, 125). Defensins are another group of proteins, which mediate antiviral 
responses. These proteins are produced by a variety of cell types, including epithelial cells, 
and induce pro-inflammatory mediator production as well as the release of other cytokines 
important for innate antiviral defenses (237, 255). Again, this summary of the innate immune 
response to influenza is in no way a comprehensive review of the host’s antiviral response. 
Instead it covers the main aspects of antiviral defenses and gives a general understanding of 
the topics, which will be further investigated herein.  
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Toll-like Receptors 
Toll-like receptors (TLRs) are an important first recognition step in response to bacterial 
and viral infection.  These receptors are members of the Interleukin-1 receptor (IL-1R) 
superfamily and share homology in the cytoplasmic region referred to as the Toll/IL-1R 
(TIR) domain.  The TIR domain serves as a scaffold for other proteins to initiate a common 
signaling process. To date, 11 members of this family have been identified in mammals. The 
receptors can be located on the cell surface bound to the plasma membrane or intracellularly 
associated with endosomal membranes. TLRs recognize conserved pathogen-associated 
molecular patterns (PAMPs) and downstream signaling leads to the production of innate 
immune defense mediators as well as activation of  adaptive immune responses (1, 2). Toll-
like receptor 3 (TLR3) is activated by double-stranded RNA (dsRNA), a molecular pattern 
commonly associated with viral infection, and mediates the activation of numerous 
downstream signaling proteins and transcription factors, ultimately eliciting production of 
inflammatory cytokines and type I interferons (3, 132). 
 TLR3 mRNA has been found in human lung, liver, heart, placenta, pancreas, as well as 
brain (174). It is also expressed in dendritic cells, NK cells, intestinal epithelial cells, as well 
as airway and respiratory epithelial cells (27, 67, 79, 144, 201, 240). Localization of TLR3 
within the cell is variable.  Surface or cytoplasmic expression of TLR3 has been 
demonstrated in various cell types (67, 131, 132, 201). The most likely explanation for these 
differences is that TLR3 expression as well as its localization is cell type specific.  
Additionally, expression of TLR3 has been shown to be up-regulated in dendritic cells as 
well as in bronchial and respiratory epithelial cells by viral infection or dsRNA treatment in 
the form of polyinosinic:polycytidylic acid (poly(I:C)) (67, 103, 131, 177, 223). There is also 
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recent evidence that in addition to causing up-regulation, viral infection also causes a shift in 
the localization of TLR3 from cytoplasmic to surface expression (65). 
TLR3 Signaling 
 The actual signal cascade elicited by TLR3 differs between cell types and viruses. For the 
purpose of this review a simplified overview of the TLR3 signal cascade will be given (see 
figure 1A) and discrepancies that may exist will be pointed out in the text. It is generally 
accepted that once TLR3 is activated by dsRNA it recruits the adaptor protein TIR domain-
containing adaptor inducing IFN-β (TRIF) through an interaction of TIR domains in each 
protein (154, 254). Phosphorylation of TLR3 on tyrosine residues is an important step for this 
recruitment (189, 190). The TLR3 signaling cascade diverges at TRIF with one branch of the 
signaling cascade leading to the activation of nuclear factor-kappa B (NF-κB) with 
subsequent of pro-inflammatory cytokines and the other branch of the signaling cascade 
leading to the activation of interferon regulatory factor (IRF) 3 and IFN-β production. The 
inflammatory pathway involves tumor necrosis factor (TNF) receptor-associated factor 
(TRAF) 6 which is recruited and bound by TRIF (90, 191). TRAF6 forms a complex with 
TAK1, TAB 1 and 2, and possibly eukaryotic translation initiation factor 2-alpha kinase 2 
(PKR), which leads to the activation of NF-κB (90). There is also evidence that receptor 
interacting protein (RIP) -1 is recruited by TRIF and is needed for NF-κB activation (134). 
The other branch of the TLR3 signaling pathway results in the production of type I 
interferons resulting in the activation of IRF3, which translocates to the nucleus and binds the 
interferon response element (ISRE) of the IFN-β promoter thereby activating its transcription 
(49, 247). Activation of IRF3 is achieved by a dual phosphorylation. It is generally accepted 
that TANK-binding kinase (TBK) 1, which is also recruited by TRIF, is one of the kinases 
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that phosphorylates IRF3 (53, 202).  The additional phosphorylation of IRF3 is thought to be 
mediated by Akt or one of its downstream components. Upon activation, TLR3 is 
phosphorylated on tyrosine residues and recruits Phosphatidylinositol-3 kinase (PI3k), which 
then activates Akt (190). Akt or a downstream component of Akt then phosphorylates IRF3 
leading to its complete activation, dimerization, and nuclear translocation. There is also 
evidence that IKKε provides the second phosporylation event (53, 202), but its function may 
be redundant with that of TBK1 (158). 
Type I interferon signaling 
 Interferons (IFNs) are cytokines that have anti-viral, anti-proliferative, and 
immunomodulatory effects. These molecules are important role in the innate immune 
defenses against invading pathogens and also activate adaptive responses. There are a 
number of type I IFNs found in humans, including IFN-α, of which there are 13 subtypes, 
IFN-β, IFN-ε, IFN-κ, and IFN-ω. Once secreted, type I IFNs bind the IFNα receptor 
(IFNAR), which activates a signaling cascade that results in the transcription of numerous 
interferon-stimulated genes (ISGs) (see figure 1B). Binding of type I IFNs to the IFNAR 
results in a dimerization of the receptor subunits, IFNAR1 and 2, leading to 
autophosphorylation and activation of associated proteins: Janus activated kinase 1(JAK1) 
and tyrosine kinase 2 (TYK2) (reviewed in 165). These in turn activate signal transducer and 
activator of transcription (STAT) 1 and 2, which form a complex along with IRF9 known as 
IFN-stimulated gene factor 3 (ISGF3). ISGF3 then translocates to the nucleus where it binds 
with ISREs to initiate gene transcription. Recently, there has been evidence of alternative 
pathways and protein components, but the scope of this information is beyond this review. 
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The pathway described here is the main type I IFN signaling pathway and will be the one we 
focus on in elucidating the involvement of type I interferons in TLR3 expression.  
Summing Up 
 Epidemiological studies have noted an association between levels of air pollutants and 
the incidence of respiratory infections. Furthermore, experimental studies have shown that 
exposure various air pollutants can enhance the susceptibility and response to a number of 
respiratory diseases. Considering that the most common form of illness in the U.S. and 
Europe is respiratory allergies and infections, which account for more missed work as well as 
school days than any other disease, it is important to understand the associations between, the 
potential effects of, and the mechanisms involved in air pollution-induced exacerbation of 
respiratory infections. Therefore, this dissertation will focus on elucidating the effects of 
diesel exhaust exposure on the host response to respiratory viral infection. Specifically, the 
effect of DE exposure on the susceptibility and response to influenza infections was 
examined both in vitro and in vivo as well as some of the mechanistic aspects involved in the 
observed effects. The results presented herein provide evidence that exposure to DE can 
enhance the susceptibility to influenza infections as well as the innate immune response to 
viral infection through an increase in the expression and signaling of TLR3.  
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Chapter 2 
Diesel Exhaust Enhances Virus- and poly(I:C)-induced Toll-like Receptor 3 Expression 
and Signaling in Respiratory Epithelial Cells 
 
Introduction 
Adverse health effects induced by exposure to air pollution have become an increasing 
problem in many areas worldwide. Although many different emission sources account for the 
complex air pollution mixture in urban environments, diesel exhaust (DE) has raised a fair 
amount of concern, since it can account for a significant percentage of air pollutants 
generated by motor vehicles in many places (42, 234). In addition, epidemiological data and 
experimental studies suggest that DE is a major contributor to adverse health effects 
associated with exposure to particulate air pollutants (235, 249). Due to their small mass 
median diameter (0.05-1.0µm), DE particles are easily respirable and capable of being 
deposited in the lower airways and alveoli (32, 209). The carbonaceous core of these 
particles can absorb around 18,000 chemical compounds onto it, including polyaromatic 
hydrocarbons, which are suspected to play a major role in the adverse health effects induced 
by exposure to DE (250). Additionally, it has been shown that exposure to DE and DE 
particulates increases neutrophil recruitment and pulmonary inflammation in both rodents 
and humans (93, 148, 150, 178, 179, 180, 183, 257).  Furthermore, DE has also been 
implicated in having adverse effects on host immunity. It has been shown that DE increases 
the cellular responsiveness to histamine (75, 100) and acts as an adjuvant to IgE production 
(44, 55, 143, 149, 230). In addition, epidemiological evidence has noted an association 
between ambient particulate matter and pulmonary infections (166), including exacerbation 
of respiratory symptoms associated with infection (30, 58, 155). Exposure to DE can also 
enhance the susceptibility to respiratory virus infections. Specifically, our previous studies 
have demonstrated that exposure to an aqueous-trapped solution of DE (DEas) enhances the 
susceptibility to influenza infections in human respiratory epithelial cells (85). Other studies 
have shown that mice repeatedly exposed to DE showed an increased susceptibility to 
infection with RSV, as shown by increased inflammatory responses and levels of viral titers 
following infection with RSV (71). These studies indicate that exposure to DE can increase 
the susceptibility and exacerbate responses to respiratory virus infections. However, the 
mechanism by which exposure to DE modulates the host response to respiratory virus 
infections is not yet clear.    
The host’s first line of defense against an invading pathogen is the innate immune 
response.  It activates the secondary immune response and keeps the infection under control 
until the adaptive response is mobilized.  An integral role in the innate immune response is 
played by toll-like receptors (TLRs).  These receptors are members of the superfamily of 
Interleukin-1 receptors (IL-1R) and share homology in the cytoplasmic region referred to as 
the Toll/IL-1R (TIR) domain.  TLRs recognize conserved pathogen-associated molecular 
patterns (PAMPs); recognition leads to the production of innate immune defense mediators 
as well as activation of the adaptive immune response (1, 2, 84). Toll-like receptor 3 (TLR3) 
recognizes double-stranded RNA (dsRNA), a molecular pattern commonly associated with 
viral infection. DsRNA stimulates TLR3 signaling, which culminates in the activation of 
numerous downstream signaling proteins and transcription factors and ultimately results in 
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production of inflammatory cytokines and type I interferons (3, 132). Expression of TLR3 
has been shown to be up-regulated in dendritic cells as well as in bronchial and respiratory 
epithelial cells by viral infection or dsRNA treatment in the form of 
polyinosinic:polycytidylic acid (poly(I:C)) (67, 103, 131, 177, 223). 
The respiratory epithelium is a common target for both DE as well as invading 
respiratory viruses.  Since TLR3 plays such an integral role in the recognition and primary 
response to viral pathogens the purpose of this study was to examine the effects that pre-
exposure to DE had on TLR3 expression and signaling in respiratory epithelial cells. 
Specifically, we examined whether exposure to an aqueous-trapped solution of DE (DEas) 
enhances TLR3 expression and TLR3-dependent signaling in response to dsRNA or 
influenza virus infections in human respiratory epithelial cells. The results demonstrate that 
exposure to DEas significantly increased TLR3 expression as well as TLR3-mediated innate 
immune responses in epithelial cells infected with influenza virus or treated with dsRNA.   
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Materials and Methods 
Cell Culture 
A549 cells, a human pulmonary type II epithelial-like cell line were cultured in F12K 
medium plus 10% fetal bovine serum and 1% penicillin and streptomycin (all from 
Invitrogen, Carlsbad, CA). For treatment with DEas and stimulation with poly(I:C), A549 
cells were grown in 6 or 24-well plates.  When the cells reached about 80% confluency and 
about 18-24h before exposure to DEas and stimulation with poly(I:C), the cell culture media 
was exchanged for serum-free F12K plus 1.5µg/ml BSA plus antibiotics. In some 
experiments 1µM wortmannin (Calbiochem, La Jolla, CA) was added 30 minutes before 
treatment with DEas.  Primary human bronchial epithelial cells were obtained from healthy 
nonsmoking adult volunteers by cytologic brushing at bronchoscopy. Primary human nasal 
epithelial cells were obtained from healthy nonsmoking adult volunteers by gently stroking 
the inferior surface of the turbinate several times with a Rhino-Probe curette (Arlington 
Scientific, Arlington, TX), which was inserted through an otoscope with a large aperture. The 
protocols for the acquisition of both primary human bronchial and nasal epithelial cells were 
reviewed by the University of North Carolina Institutional Review Board. Both primary 
human bronchial and nasal epithelial cells were expanded to passage 2 in bronchial epithelial 
growth medium (BEGM, Cambrex Bioscience Walkersville, Inc., Walkersville, MD ) and 
then plated on collagen-coated filter supports with a 0.4 µM pore size (Trans-CLR; Costar, 
Cambridge, MA) and cultured in a 1:1 mixture of bronchial epithelial cell basic medium 
(BEBM) and DMEM-H with SingleQuot supplements (Cambrex), bovine pituitary extracts 
(13mg/ml), bovine serum albumin (BSA, 1.5 µg/ml), and nystatin (20 units). Upon 
confluency, all-trans retinoic acid was added to the medium and air liquid interface (ALI) 
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culture conditions (removal of the apical medium) were created to promote differentiation. 
Mucociliary differentiation was achieved after 18-21 days post-ALI.  
Generation of A549-TRAF6 DN cells 
 
A549 cells stably transduced with dominant negative TRAF6 were prepared as follows. The 
sequence encoding a truncated form of TRAF6 was digested out of the plasmid pCIneo-
TRAF6 DN (TRAF6 289-530), kindly provided by Dr. R. Medhzitov’s lab (Howard Hughes 
Medical Institute, Yale University Medical School, New Haven, CT, U.S.A.) (26) using 
EcoRI and SalI restriction enzymes (New England Biolabs, Ipswich, MA) and ligated into 
EcoRI and SalI digested pBabe-puro, which was a kind gift from Dr. A. Baldwin (Lineberger 
Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, U.S.A.). The 
pBabe-puro-TRAF6 DN retroviral vector was transfected into retroviral packaging PT67 
cells and stably transfected cells were selected using 1µg/ml puromycin (Sigma). As a 
control, pBabe-puro alone was transfected into PT67 cells. Retroviral-laden supernatants 
were harvested periodically and stored at -80oC until use. Immediately before use, 
supernatants were filtered through 0.45µm filters and supplemented with 8µg/ml polybrene 
(Sigma).  A549 cells grown to about 50% confluency were transduced using the retrovirus 
containing supernatants and stably transduced A549 cells were selected using 1µg/ml 
puromycin for about two weeks. Expression of TRAF6 DN in stably transduced A549 cells 
was confirmed by Western blotting. 
Exposure to aqueous-trapped solution of Diesel Exhaust (DEas) 
DEas was generated as described before (123). Briefly, emissions were taken from a 
Caterpillar diesel engine, model 3304, which was used to power a 113 KW generator. This 
type of engine was chosen because it is used in non-road vehicles, which are significant 
 17
contributors to ambient diesel exhaust levels and because the projected trend for emissions 
from non-road diesel engines was expected to remain at the same level or decline slowly in 
the future at the time of experimental design (235). The diesel exhaust emissions from this 
Caterpillar diesel engine were passed through a tubing system with a filter impactor and 2 
impinger tubes (containing 100 ml PBS each) submerged in an ice bath. Impinger glassware 
had been washed and heated to remove and destroy endotoxin. Of the two impinger tubes, 
the emissions (at 10 L/min) that entered and remained in the first (primary) tube, but not the 
secondary tube, were utilized for the cell exposure studies. Extracts were generated and 
collected during a one-hour period when the engine was under high load (HL). This type of 
preparation was chosen, because it contains both DE particles as well as polar and thus 
water-soluble DE gas-phase components. To determine the mass of the emissions retained 
within the PBS in an impinger tube, an aliquot was dried overnight at 56ºC, and corrected for 
the mass of the PBS contribution (which was determined in a similar manner by overnight 
drying) and dilution with water from the exhaust. Aliquots of the DEas were kept at - 80ºC 
until use. For all cell types used in this study, DEas was added 2 hours before infection with 
influenza or treatment with poly(I:C). Specifically, for the differentiated human nasal and 
bronchial epithelial cells, DEas was diluted in 200µl media to achieve 22 or 44µg DEas per 
cm2 of cell layer and added to the apical side. After the 2 hours incubation with DEas, the 
diluted DEas was removed and influenza virus or poly(I:C) was diluted in the same volume of 
media was added to the apical side for 2 hours, after which it was removed to establish ALI 
culture conditions again. For the experiments using A549 cells, DEas was diluted in F12K 
media plus BSA plus antibiotics to achieve 25µg/cm2 and added to the cells. After 2 hours 
incubation with DEas, poly(I:C) was added to the cells. The effects of exposure to DEas on 
 18
cell viability were assessed by analyzing cell culture supernatants for lactate dehydrogenase 
(LDH) activity using a commercially available kit according to the supplier’s instructions 
(CytoTox 96®, Promega, Madison, WI). 
Exposure to different diesel exhaust preparations, extractable organic material (EOM), and 
particle solutions 
 
Diesel Exhaust was collected as previously described (25). Briefly, standard reference 
material (SRM) 2975 was obtained from the National Institute of Sciences and Technology 
(NIST, Minneapolis, MN) and was generated from a heavy-duty diesel forklift engine and 
collected under “hot” conditions. Comp-DEP was obtained from Dr. Ian Gilmour (U.S. EPA) 
and was generated from a 30kW (40hp) 4 cylinder diesel engine powering a compressor. 
Particles were weighed then dissolved in PBS + 0.005% BSA. Mt. St. Helens Dust (MSHD) 
and ultrafine carbon particles were used as particle controls. For A549 cells, particle 
solutions were diluted in F12K media plus BSA plus antibiotics to achieve 25µg/cm2 and 
added to the cells. After 2 hours incubation with particle solutions, poly(I:C) was added to 
the cells. For experiments involving the EOM of Comp-DEP, cells were treated with an 
amount of extract that was equivalent to the amount, which would be present in a dose of 
25µg/cm2 of Comp-DEP assuming that this preparation contains 30% organic material. For 
these experiments vehicle control cells were exposed to the equivalent volume of DMSO. 
EOM or DMSO was diluted in the media and added to the cells for 2 hours prior to the 
addition of poly(I:C).  
Infection with influenza or treatment with poly(I:C) 
Throughout this study we used influenza A/Bangkok/1/79 (H3N2 serotype) which was 
propagated in 10-day-old embryonated hen’s eggs. The virus was collected in the allantoic 
fluid and titered by 50% tissue culture infectious dose in Madin-Darby canine kidney cells 
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and hemagglutination as described before (11). Stock virus was aliquoted and stored at -80oC 
until use. Unless otherwise indicated, for infection of differentiated bronchial or nasal cells 
approximately 3 X105cells were infected with 320 (hemagglutination units) HAU of 
influenza A Bangkok 1/79. Cells were treated with 100 µg/ml of polyinosinic 
acid:polycytidylic acid (poly(I:C)) (Calbiochem; La Jolla, CA) 2 hours after exposure to 
DEas. 
Transfection with siRNA 
siRNA for TLR3, PKR, and Lamin was obtained from Dharmacon (Layfayette, CO) and 
cells were transfected according to the supplier’s instructions. Briefly, A549 cells were 
transfected with 500 µg of siRNA, which was added to the cell media, 24 hours prior to 
infection with influenza. Targeted knock-down was confirmed by real-time RT-PCR of the 
specific gene product. 
RT-PCR 
 
Total RNA was extracted using TRizol (Invitrogen) as per the supplier’s instruction. First-
strand cDNA synthesis and real-time RT-PCR was performed as described previously (86, 
87). The sequences for the primers and probes used in this study are as following: HA: probe, 
5’-FAM-TGATGGGAAAAACTGCACACTGATAGATGC-TAMRA-3’; sense, 5’-
CGACAGTCCTCACCGAATCC-3’; antisense, 5’-TCACAATGAGGGTCTCCCAATAG-
3’; IFN-β: probe, 5’-FAM-AGCAGCAATTTTCAGTGTCAGAAGCTCCTG-TAMRA-3’; 
sense, 5’- CAACTTGCTTGGATTCCTACAAAG-3’; antisense, 5’-
AGCCTCCCATTCAATTGCC-3’;IL-6: probe, 5’-FAM-
TGTTACTCTTGTTACATGTCTCCTTTCTCAGGGCT-TAMRA-3’; sense, 5’-
GGTACATCCTCGACGGCATCT-3’; antisense, 5’- GTCCCTCTTTGCTGCTTTCAC- 3’; 
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TLR3: probe, 5’-FAM-ATGCAGTTCAACAAGCTATTGAACAAAATCTGGA-TAMRA-
3’; sense, 5’- ATTAAAAGACCCATTATGCAAAAGATTC- 3’; antisense, 5’-
CCTCAAGGAAAACCAATATAATGGA-3’; MxA: probe, 5’-FAM-
AGGCCAGCAAGCGCATCTCCAG-TAMRA-3’; sense, 5’-
CAGCACCTGATGGCCTATCAC-3’, antisense, 5’-
CATGAAGAACTGGATGATCAAAGG-3’; GAPDH: probe, 5’-JOE-
CAAGCTTCCCGTTCTCAGCC-TAMRA-3’; sense, 5’-GAAGGTGAAGGTCGGAGTC-
3’; antisense, 5’-GAAGATGGTGATGGGATTTC-3’. mRNA analyses for β-actin, RIG-I, 
and PKR were performed using commercially available primer/probe sets (inventoried 
Taqman® Gene Expression Assays) purchased from Applied Biosystems (Foster City, CA).  
ELISA  
Supernatants were analyzed for IL-6 using commercially available ELISA kits as per the 
supplier’s instructions (BD Biosciences; San Diego, CA). 
Western blotting 
 
Whole cell lysates were prepared by lysing the cells in RIPA buffer containing 1% Nonidet P 
(NP)-40, 0.5% deoxycholate, 0.1% SDS, and protease inhibitors (Cocktail Set III; 
Calbiochem, San Diego, CA). Nuclear extracts were prepared as described before (87). 20-
100 µg of whole cell lysate or 20-50µg of nuclear extract was separated by SDS-PAGE as 
described before (87). This was followed by immunoblotting using specific antibodies to 
TLR3 (1:200, Santa Cruz Biotechnology, Santa Cruz, CA), IRF3 (1:1000, Santa Cruz 
Biotechnology), phospho-Akt (1:1000, Cell Signaling, Beverly, MA), or Akt (1:1000, Santa 
Cruz Biotechnology).  β-actin (1:2000, USBiological, Swampscott, MA) was used as a 
loading control for TLR3. Antigen-antibody complexes were stained with anti-rabbit or anti-
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mouse, horseradish peroxidase-conjugated antibody (1:4000, Santa Cruz Biotechnology) and 
SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL). The 
chemiluminescent signals were acquired using a 16-bit CCD camera (GeneGnome system; 
Syngene, Frederick, MD) and visualized using the GeneSnap software (Syngene).  
Densitometric analysis of the optical densities was performed using GeneTools Software 
(Syngene).  
Immunohistochemistry/Confocal Microscopy 
 
A549 cells were grown on chamber slides (Lab-Tek® Chamber slides, Nalge Nunc 
International,Naperville, IL). Cells were prepared as described previously (57) with slight 
modifications.  Briefly, cells were fixed with 4% paraformaldehyde in PBS for 30 min, and 
then permeabilized with 0.5% saponin in 1% BSA in PBS for 30 min.  Samples were washed 
with PBS then blocked in 1% BSA in PBS for 1 hour.  Cells were washed in PBS then 
treated with anti-TLR3 mAB (TLR3.7) (1:10; ebioscience, San Diego, CA) overnight at 4º C.  
A no primary control was also done.  Cells were washed in TBS then treated with goat anti-
mouse Alexa 488 conjugated secondary antibody (5µg/ml, Molecular probes) in TBS/Triton 
for 1 hour at room temperature.  Cells were then washed in TBS and cover slipped with 
VectaShield with DAPI (Vector Labs, Burlingame, CA).  Immunofluorescence was 
visualized using a Zeiss 510 laser scanning confocal microscope at the Michael Hooker 
microscopy core facility at the University of North Carolina at Chapel Hill. 
Flow Cytometry 
A549 or differentiated NHBE cells were detached by incubating with 0.53mM EDTA/PBS at 
37oC for 10 minutes and were washed HBSS. For the analysis of TLR3 the cell pellets were 
resuspended at 106 cells/ml.  For intracellular staining of TLR3, cells were permeabilized and 
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fixed by incubating them with Cytoperm/Cytofix (BD Bioscience; San Diego, CA) as per the 
supplier’s instructions and then washed twice with staining solution containing 1.0% bovine 
serum albumin and 0.02% sodium azide in PBS. This step was omitted for cells that were 
stained for surface expression of TLR3. Cells were then incubated with Phycoerthrin (PE)-
conjugated anti-TLR3 (TLR3.7) (1 µg/106 cells, Ebioscience; San Diego, CA) or PE-mouse 
IgG1 (1 µg/106 cells) for 30 min at 4 oC then washed twice with staining solution.  Cells 
stained for surface expression of TLR3 were then fixed by incubating them with 1% 
paraformaldehyde for 20 min at 4ºC. Data acquisition and analysis was performed on a flow 
cytometer (FACScan using the Cell Quest software; Becton Dickinson, Mountain View, CA). 
Ten thousand cells were examined for each determination.  
Statistical Analysis 
 
Data are expressed as means + S.E.M. of at least three separate experiments. Data from 
experiments involving primary human nasal or bronchial epithelial cells were analyzed using 
the Wilcoxon matched-pairs test. Data generated from experiments using A549 cells were 
analyzed using two-way analysis of variance to determine if there was a significant 
interaction between the exposure (DEas) and treatment (poly(I:C)), followed by the Tukey-
Kramer HSD post hoc test for multigroup analysis, except for the data in figure 7, which 
were analyzed using the Wilcoxon Signed Rank Test, assuming a theoretical mean of 1.00 
for the control group. A value of p <0.05 was considered to be significant. 
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Results 
TLR3 Expression and Localization 
 
   The TLR’s involved in recognition of non-viral pathogen-associated molecular patterns 
(PAMPs) are anchored in the cell membrane, with the PAMP recognizing portion on the 
extracellular side and the TIR domain on the cytoplasmic side (200). However, the exact 
cellular location of TLR3 in respiratory epithelial and other cell types is still controversial, 
with the most recent data indicating that TLR3 is located in cytoplasmic vesicles. Therefore, 
the first objective was to characterize the expression and localization of TLR3 in respiratory 
epithelial cells.  Using a PE-conjugated anti-TLR3 antibody the surface and cytoplasm were 
both stained for TLR3 in A549 cells and flow cytometric analysis was performed to identify 
TLR3-stained cells. Permeabilization followed by fixation was used to analyze cytoplasmic 
expression of TLR3, while surface expression was assessed in cells that did not receive the 
permeabilizing treatment.  The results indicate that TLR3 was located predominantly in the 
cytoplasm with little or no surface expression evident (Fig 2A). This was also confirmed in 
differentiated human bronchial epithelial cells and similar results were observed (data not 
shown).  To further identify cytoplasmic compartments in which TLR3 is localized, indirect 
immunofluorescent staining of A549 cells for TLR3, followed by visualizing the fluorescent 
staining using confocal microscopy was performed. Figure 2B indicates that the staining for 
TLR3 was distributed throughout the cytoplasm, without any staining concentrating along the 
cell membrane or the nucleus. In addition, the staining pattern seemed granular, confirming 
previous observations of TLR3 being located in cytoplasmic vesicles (57, 131).  
Effect of DEas on TLR3 expression     
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After identifying the localization of TLR3, it was examined whether the expression of 
TLR3 was affected in cells exposed to DEas prior to viral infection or treatment with dsRNA, 
which are both stimuli that have previously been shown to enhance TLR3 mRNA levels (67, 
177, 201, 223). DE has previously been shown to exacerbate inflammatory mediator 
production in response to RSV in mice (71) and IFN-β expression in response to influenza in 
respiratory epithelial cells (85), yet the role of TLR3 in these responses is unknown.  
Therefore, we wanted to determine if exposure to DEas could enhance virus-induced 
expression of TLR3.  To do this, levels of TLR3 mRNA were examined in differentiated 
human respiratory epithelial cells exposed to DEas and subsequently infected with influenza. 
Similar to previous results (223), Figure 3 shows that infection with Influenza enhanced 
TLR3 mRNA levels as compared to uninfected control cells, although this effect was not 
statistically significant in the bronchial cells. As expected, exposure to DEas alone did not 
significantly enhance TLR3 mRNA levels in either differentiated human nasal or bronchial 
epithelial cells. However, when cells were exposed to DEas prior to infection with Influenza 
there was a significant enhancement of the Influenza-induced up-regulation of TLR3 mRNA 
levels in bronchial epithelial cells and an increase that was approaching statistical 
significance in nasal epithelial cells (p=0.06).   
These experiments were repeated using poly(I:C), a synthetic form of double-stranded 
RNA, instead of the Influenza virus to induce TLR3 expression in A549 cells, a human 
respiratory epithelial cell line. Figure 4A shows that, although not significant, treatment with 
poly(I:C) alone caused a modest up-regulation of TLR3 mRNA in A549 cells and exposure 
to DEas alone had no effect on TLR3 mRNA levels in this cell type.   When cells are pre-
exposed to DEas before stimulation with poly(I:C) however, there was a significant 
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interaction between DE exposure and poly(I:C) treatment resulting in a significant up-
regulation of TLR3 mRNA levels above each single treatment.  To determine whether the 
enhanced TLR3 mRNA levels correspond to enhanced TLR3 protein expression, TLR3 
protein levels were analyzed in whole cell lysates by Western blotting. Figure 4B shows that 
the up-regulation of TLR3 seen at the mRNA level in cells exposed to DEas prior to 
stimulation with poly(I:C) translated into increased TLR3 protein expression in A549 cells.  
Densitometric readings expressed as fold induction over the media control show that 
exposure of cells to DEas prior to stimulation with dsRNA enhanced TLR3 expression. Taken 
together, the results demonstrate that exposure to DEas significantly enhances virus or 
dsRNA-induced TLR3 expression in different human respiratory epithelial cell types. 
DEas increases poly(I:C)-induced inflammatory mediator production 
 
Stimulation of TLR3 by dsRNA or viral infection results in the activation of two separate 
signaling pathways, one culminating in the activation of Interferon regulatory factors (IRFs) 
and the production of type I IFNs and the other in the activation of NF-κB and the production 
of pro-inflammatory mediators. Production of inflammatory mediators is a common response 
of respiratory epithelial cells to viral infections and can be exacerbated by a number of 
environmental pollutants (71, 205). After observing an up-regulation of TLR3 expression by 
prior exposure to DEas, it was determined whether exposure to DEas also enhanced TLR3-
mediated pro-inflammatory mediator production by analyzing the expression of IL-6 in cells 
exposed to DEas and stimulated with poly(I:C). Using real-time RT-PCR, IL-6 mRNA levels 
were analyzed 24 hours after exposure to DEas and stimulation with poly(I:C) in A549 cells. 
Figure 5A shows that levels of IL-6 mRNA were slightly elevated in response to treatment 
with poly(I:C) alone. Exposure to DEas alone had no effect IL-6 mRNA levels.  When cells 
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were exposed to DEas prior to treatment with poly(I:C), IL-6 mRNA levels were significantly 
increased above the media control despite the fact that there was not a significant interaction 
between exposure and treatment.  To validate the IL-6 mRNA levels,  IL-6 protein levels 
were also measured in cell culture supernatants and a similar overall effect was observed (Fig 
5B). Specifically, there was a significant interaction between exposure and treatment 
resulting in a significant increase in secretion of IL-6 above all other groups in cells exposed 
to DEas prior to treatment with poly(I:C). These findings along with the mRNA data show 
that exposure to DEas increases the TLR3-mediated inflammatory response.  
To assure that the effect of DEas on poly (I:C)-induced IL-6 expression was mediated by 
TLR3 and not other TLR3-independent pathways, such as PKR-dependent activation of NF-
κB and production of inflammatory cytokines (156), IL-6 production was examined in cells 
overexpressing dominant negative mutant form of TNF receptor-associated factor 6 (TRAF6) 
lacking the N-terminal zinc binding structures (26). Although several other signaling 
pathways converge at TRAF6 to subsequently activate NF-κB and enhance inflammatory 
cytokine production, TRAF6 is also one of the main signaling proteins involved in the TLR3-
mediated inflammatory response (89). Using retroviral expression vectors, A549 cells were 
stably transduced with the control vector or a vector expressing a truncated form of TRAF6 
(26). Both cell lines were exposed to DEas, stimulated with poly(I:C), and IL-6 mRNA levels 
were quantified 24 hours after stimulation with poly(I:C) using real time RT-PCR. Figure 6 
shows that cells transduced with a control vector responded similarly to those in Figure 5A, 
whereby IL-6 mRNA levels were significantly increased above control in cells exposed to 
DEas prior to treatment with poly(I:C), despite the absence of a significant interaction effect. 
However, when cells expressing the dominant negative form of TRAF6 (dnTRAF6) were 
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exposed to DEas prior to treatment with poly(I:C) there was no significant up-regulation of 
IL-6 mRNA levels as seen in cells expressing the control vector. Additionally, the IL-6 levels 
observed in the dnTRAF6 cells treated with DEas + poly(I:C) were decreased compared to 
control cells treated in the same manner.  Interestingly, IL-6 expression was not completely 
abrogated in cells expressing dnTRAF6, which could be mediated by the endogenously 
expressed wild type form of TRAF6 or TRAF6 independent pathways. Nevertheless, the 
results show that the effects of DEas on poly (I:C)-induced IL-6 production were largely 
dependent on TRAF6, an integral component of the TLR3 signaling pathway. 
DEas enhances the poly(I:C)-induced IFN-β expression 
After elucidating the effects of DEas on poly (I:C)-induced IL-6 expression, we examined 
how exposure to DEas affected IFN-β expression after stimulation with poly(I:C).  IFN-β is a 
type I interferon with anti-viral properties produced early on during viral infections (114, 
225). The same exposure and treatment regimen was used as before and levels of IFN-β 
mRNA were quantified 24 hours after treatment with poly(I:C) using real-time RT-PCR (Fig 
7A).  No significant increase in mRNA levels were seen in cells exposed to DEas or poly(I:C) 
alone. However, there was a significant interaction with DEas exposure and poly(I:C) 
resulting in a significant increase in IFN-β mRNA levels, indicating that TLR3-mediated 
IFN-β production is also enhanced by exposure to DEas.    
TLR3-mediated expression of IFN-β is dependent on Interferon regulatory factor 3 
(IRF3), which is the main transcription factor controlling IFN-β transcription (127, 146, 
224). To determine whether exposure to DEas enhances poly(I:C)-induced IFN-β expression 
at the transcriptional level, nuclear levels of IRF3 were determined. A549 cells were exposed 
and treated as before and western blotting was used to assay levels of IRF3 in nuclear 
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fractions harvested 4 hours after stimulation with poly(I:C) (Fig 7B).  Treatment with DEas or 
poly(I:C) alone resulted in a mild increase in the levels of nuclear IRF3.  Similar to the IFN-β 
mRNA levels, cells exposed to DEas prior to stimulation with poly(I:C) had greater levels of 
nuclear IRF3 compared to cells only stimulated with poly (I:C). Together these results show 
how pre-exposure to DEas can up-regulate IFN-β levels through enhanced activation of IRF3.  
Role of AKT in IFN-β production 
Since an increase in IFN-β mRNA levels and increased nuclear levels of IRF3 were 
observed in cells exposed to DEas and subsequently stimulated with poly (I:C), the upstream 
components of the TLR3-mediated interferon pathway were examined. Specifically, the role 
of the phosphatidylinositol-3 kinase (PI3K) pathway in the DEas-induced up-regulation of 
IFN-β was of interest since evidence suggests that Akt, the downstream component of PI3K, 
is responsible for phosphorylating IRF3, which is required for complete activation of the 
transcription factor (180). Prior to exposure to DEas and stimulation with poly(I:C), cells 
were pre-treated with wortmannin to inhibit activation of PI3K and thus Akt. These cells 
were then analyzed for IFN-β mRNA levels by real-time RT-PCR. Figure 8A shows that in 
cells pre-treated with the vehicle control, exposure to DEas prior to treatment with poly(I:C) 
significantly increased levels of IFN-β mRNA. However, when cells were pre-treated with 
the PI3K inhibitor wortmannin, IFN-β mRNA levels were not significantly enhanced. To 
obtain further support for the participation of Akt in the effects of DEas on poly(I:C)-induced 
IFN-β expression, levels of phosphorylated and thus activated Akt were analyzed in whole 
cell lysates using Western blotting (Fig 8B).  Exposure to DEas increased the levels of 
phosphorylated Akt compared to control and poly(I:C)-treated cells.  Taken together, the 
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results suggest that the effects of DEas on poly(I:C)-induced IFN-β expression are partially 
mediated by the effects of DEas on Akt activity.   
Effects of different diesel exhaust preparations on the expression of pattern recognition 
receptors, pro-inflammatory cytokines, and IFN-β 
 
As stated earlier, the composition of DE can vary depending on the source it was derived 
from. Furthermore, there is evidence that organic components adsorbed onto DEPs are 
responsible for many of the adverse effects associated with exposure to DE (28, 221, 222). 
Given the previous observations with DEas, which was generated from an engine used to 
power a generator, and its effect on TLR3 expression and signaling, the effect of different 
diesel exhaust and particle preparations on the expression of TLR3 was examined. To expand 
the focus of the effects of DE on influenza-induced expression and function of pattern 
recognition receptors (PRRs) and other antiviral mediators, changes in the expression of 
retinoic acid-inducible protein I (RIG-I), and eukaryotic translation initiation factor 2-alpha 
kinase 2 (PKR) were also examined. In addition, mRNA expression of the pro-inflammatory 
cytokines/chemokines IL-6, IL-8, and regulated on activation, normal T-cell expressed, and 
secreted (RANTES), as well as the type I interferon, IFN-β were examined. The preparations 
used were: 1) Standard reference material (SRM) 2975, which is derived from an industrial 
forklift and has a low percentage of organic material; 2)Compressor DEP (Comp-DEP), 
which was obtained from a diesel engine powering a compressor and has an intermediate 
percentage of organic material; 3) extracted organic material (EOM) from Comp-DEP; as 
well as 4) volcanic dust from the Mt. St. Helen’s eruption (MSHD) and 5) ultrafine carbon 
(UF carbon) for use as particle controls. DE from an automobile, having a high percentage of 
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organic material, was also tested, but caused cytotoxicity at the doses examined in this study 
(data not shown) so subsequent analyses were not performed.  
A549 cells were exposed to 25 µg/cm2 of each preparation for 2 hours prior to stimulation 
with poly(I:C). Levels of TLR3 (Fig 9A), RIG-I (Fig 9B), PKR (Fig 9C), IL-6 (Fig 10A), IL-
8 (Fig 10B), RANTES (Fig 10C), and IFN-β (Fig 10D) mRNA were quantified 24 hours 
after stimulation with poly(I:C).  Exposure to each preparation alone or prior to stimulation 
with poly(I:C) had different effects on the expression of the genes examined and the results 
are summarized in Table 1. Specifically, cells exposed to either MSHD or Comp-DEP prior 
to treatment with poly(I:C) showed a significant increase in mRNA levels of all genes 
examined while cells exposed to UF carbon alone showed a significant decrease in the 
mRNA levels of all genes. Cells exposed to the EOM of Comp-DEP either alone or prior to 
stimulation with poly(I:C) showed no changes in TLR3 or IL-6 mRNA levels (Fig 11) so 
further analyses were not pursued.  
Effect of siRNA on the expression of antiviral mediators 
 
In an attempt to knock-down expression of the PRRs in order to determine their 
contribution to the innate immune response to influenza infection, cells were treated with 
siRNA to TLR3, PKR, or Lamin as a control. However, an increase in the antiviral mediator 
MxA was observed in cells treated with any of the siRNAs (Fig 12A).  This resulted in a 
significant decrease in the susceptibility to infection in cells treated with siRNA for TLR3 
and PKR shown by decreased HA RNA levels (Fig 12B), and prevented a sufficient pro-
inflammatory response upon influenza infection in all siRNA treated cells shown by 
decreased IL-6 mRNA levels (Fig 12C). Thus, antiviral mediator production in response to 
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siRNA prevented the application of this technique to assess the role of TLR3 or other PRRs 
in the effects of DE on the response to influenza virus infections.  
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Discussion 
We have recently demonstrated that exposure of respiratory epithelial cells to an 
aqueous-trapped solution of diesel exhaust (DEas) increased the susceptibility to influenza 
virus infections (85). Similarly, exposure to DE has previously been shown to alter the 
response to and exacerbate respiratory symptoms associated with viral infection in mice (69, 
71). However, the mechanism(s) by which these effects occur has not yet been fully 
elucidated.  TLR3 has emerged as a key receptor eliciting pro-inflammatory mediator and 
type I IFN production in response to viral infections (130, 200). Based on current knowledge 
and previous findings in our laboratory we hypothesized that exposure to DEas affects the 
TLR3-mediated, viral response pathway and show evidence here that exposure to DEas prior 
to infection with Influenza A or stimulation with the dsRNA synthetic analog poly(I:C), up-
regulates TLR3 expression in respiratory epithelial cells obtained from different regions of 
the human respiratory tract.  This results in increased inflammatory cytokine and type I IFN 
response as demonstrated by increased levels of IL-6 and IFN-β, respectively. Taken together 
these results provide evidence for the ability of DE to alter the innate immune defense 
response against viral infection through an increase in TLR3 expression and signaling. 
 The cellular localization of TLR3 on both the cell surface and in the cytoplasm has been 
documented and appears to depend, at least in part, on the cell type (57, 67, 131, 132, 201, 
223). Using flow cytometry as well as confocal microscopy we demonstrated that in 
respiratory epithelial cells, TLR3 was located in the cell cytoplasm most likely in 
endoplasmic vesicles, as has been suggested previously (57, 131). Since uptake of RNA-
viruses, such as Influenza A, depends on the host cell’s endosomes, it is plausible that virus-
induced signaling mediating the innate immune defense response originates from this region.  
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It has been shown previously that TLR3 levels can be upregulated by viral infection in 
respiratory epithelial cells (67, 177, 223). We observed similar effects when primary, human, 
differentiated bronchial and nasal epithelial cells were infected with Influenza A virus, 
although a significant increase was not observed in bronchial cells.  Additionally, when A549 
cells were stimulated with poly(I:C) to mimic the viral by-product dsRNA, we also observed 
an increase in TLR3 mRNA levels (see figure 4). This effect, although not significant, 
mirrors what has been seen previously (67, 201) and may represents part of the epithelial 
cells’ anti-viral response mechanism to enhance the production and release of mediators 
aimed at preventing neighboring cells from becoming infected with the invading pathogen. 
Prior exposure to DEas caused a significant up-regulation of virus or dsRNA-induced TLR3 
mRNA levels that was two-four times greater than what was seen with Influenza or poly(I:C) 
alone. This effect was observed in the primary cells derived from the nasal and bronchial 
epithelium as well as the cell line derived from the alveolar region of the lung, suggesting 
that this effect occurs throughout the respiratory tract. Given the fact that the entire 
pulmonary epithelium is the primary target for both inhaled vehicle emissions, i.e. DE, as 
well as many viral infections, interaction of DE exposure with a viral infection leading to an 
up-regulation of TLR3, as demonstrated here, could significantly alter the host’s response to 
many other respiratory viral infections.   
 Stimulation of TLR3 culminates in the activation of two separate signaling cascades: A 
TRAF6-dependent pathway that mediates the activation of NF-κB and the expression of pro-
inflammatory mediators, such as IL-6, and a TANK-binding kinase-1 (TBK-1)-dependent 
pathway that mediates the activation of IRF-3 and the expression of type I IFNs. The results 
demonstrate that prior exposure to DEas caused a significant increase in both the mRNA and 
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protein levels of the pro-inflammatory cytokine IL-6 in response to stimulation with 
poly(I:C). This response was hindered in A549 cells stably transduced with a dominant 
negative form of TRAF6, which had significantly lower IL-6 mRNA levels than cells 
transduced with a control vector.  The IL-6 response was not completely abrogated in the 
dnTRAF cells due to the fact that these cells still exogenously express the wild-type form of 
TRAF6 as well as TLR3-independent pathways that may contribute to the inflammatory 
response. Nevertheless, these data further support the notion that enhanced IL-6 expression in 
cells exposed to DEas prior to stimulation with poly(I:C) was more than likely dependent on 
TLR3. Inflammatory mediators, such as IL-6 are produced by infected cells to orchestrate an 
antiviral defense response aimed at clearing the invading pathogen. However, excessive 
inflammation is detrimental to the host, causing tissue injury.  Enhancement of the IL-6 
response in an infected host could lead to increased inflammation, recruitment and activation 
of immune cells, and fever, thereby increasing the morbidity of a respiratory infection.  Thus, 
enhanced expression and function of TLR3 in cells exposed to DEas prior to viral infection is 
likely to increase lung injury. 
 As indicated above, stimulation of TLR3 also results in type I IFN expression. Similar to 
the effects seen on IL-6 expression, the data show there is a significant interaction between 
DEas exposure and treatment with poly(I:C) resulting in significantly greater IFN-β mRNA 
levels.  DEas also induced increases in the nuclear translocation of the transcription factor 
IRF3, which mediates IFN-β transcription. In addition, previous studies have shown that 
activation of the protein kinase Akt is needed to fully activate IRF3 (127, 146, 190, 224). Akt 
is activated by the upstream kinase PI3K, which is recruited and activated by TLR3 through 
phosphorylated tyrosine residues on the cytoplasmic domain of TLR3 (190). The results 
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shown here indicate that exposure to DEas, but not stimulation with poly(I:C), increase levels 
of phosphorylated and thus activated Akt. Additionally, when Akt activity was inhibited in 
A549 cells prior to exposure to DEas and stimulation with poly(I:C), there was a reduction in 
IFN-β mRNA levels as compared to the vehicle control.  Taken together these results suggest 
that the effects of DEas on virus-induced production of IFN-β are mediated by DEas-enhanced 
Akt activity. It is possible, that the effects were not entirely dependent on TLR3, since 
several signaling pathways lead to phosphorylation of Akt and activation of PI3K. This 
notion is supported by the result showing enhanced levels of phosphorylated Akt in cells 
exposed to DEas alone and by previous data demonstrating that in mouse epidermal cells, 
exposure to DE particulates enhanced the levels of phosphorylated Akt and activated NF-κB 
in a PI3K-dependent manner (120). Thus, exposure to DEas potentially affects virus-induced 
IFN-β expression via two, possibly interdependent, pathways: a) through enhancing the 
virus-induced expression and activity of TLR3 and b) through enhancing IRF3 activity by 
activating PI3K. Future analysis of these pathways and their interaction will provide a greater 
understanding of the mechanisms involved.    
Furthermore, it is possible that production and release of IFN-β, activates a positive 
feedback loop, resulting in increased TLR3 expression and further IFN-β production. 
Specifically, stimulation with the type I IFN’s, IFN-α and IFN-β, resulted in enhanced 
expression of TLR3 and increased poly(I:C)-induced signaling in A549 cells (228). We have 
previously shown that treatment with DEas significantly enhances Influenza-induced IFN-β 
expression in both primary respiratory epithelial cells and A549 cells (85). Similarly, we 
show here that treatment with DEas significantly enhances the poly(I:C)-induced IFN-β 
response and that this response may be caused by DEas-induced activation of Akt and 
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subsequent activation of IRF3 (see figures 6 and 7). Based on the findings published by 
Tissari et al. (228), it is plausible that the enhanced expression of IFN-β in cells exposed to 
DEas and stimulated with poly(I:C) activates such a positive feedback loop, resulting in the 
increased expression of TLR3.  Consequently, IFNβ-dependent enhanced expression of 
TLR3 would result in increased binding of dsRNA and therefore enhanced TLR3 signaling, 
which in turn would culminate in increased inflammatory mediator and IFN production, as 
was observed here.   
 The results presented here describe a mechanism by which exposure to DE can alter the 
innate immune defense responses against viral infections in respiratory epithelial cells, 
namely through an increase in the expression of TLR3.  By increasing TLR3 levels, DE 
enhances part of the innate immune response that is thought to provide a bridge between the 
innate and adaptive immune responses against viral infections (1, 2, 84). Within epithelial 
cells this translates into increased recruitment and activation of inflammatory and immune 
cells, which can have detrimental consequences if left unchecked.   
 Since TLR3 is largely responsible for the inflammatory response to influenza (3, 67, 103, 
104), it is likely that increased TLR3 expression results in increased inflammation during an 
influenza infection. Increased inflammation in turn would enhance the morbidity of the 
infection. Additionally, studies using TLR3-/- mice have shown that the TLR3-mediated 
inflammatory response has a detrimental contribution to the infected host and that morbidity 
and mortality are reduced in mice lacking TLR3 (103, 245). These data indicate that the DE-
induced increase in TLR3 expression and signaling will ultimately have a detrimental effect 
on an infected host. 
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 We were unable to utilize siRNA in order to further examine the role of TLR3 and other 
PRRs during an influenza infection due to the antiviral response elicited by the cell in 
response to siRNA transfection. Cells transfected with siRNA showed enhanced production 
of the anti-influenza mediator MxA, which prevented an adequate infection and subsequent 
antiviral response in these cells. Therefore, the use of siRNA technology may not be of use 
when studying cellular responses to certain viruses, particularly influenza.  
 The comparison of the different diesel exhaust preparations indicates that the effects 
observed with the aqueous-trapped solution of DE are not specific to this particular 
preparation, but are also observed when cells are exposed to DE from a compressor engine as 
well as particles from a volcanic eruption. Furthermore, another preparation of DEP did not 
cause similar effects indicating that DE from different sources may have differing effects 
depending on chemical composition as well as number of other factors. Studies have 
suggested that the organic components adsorbed onto the carbon core of DEPs are 
responsible for many of the adverse effects caused by exposure to DE (28, 221, 222). To 
determine if organic components adsorbed onto the core of DEPs were responsible for the 
observed effects in our study cells were treated with EOM from Comp-DEP and compared to 
cells treated with UF carbon, which mimics the carbon core of DEPs. Interestingly, neither 
exposure to the EOM of Comp-DEP nor UF carbon prior to stimulation with poly(I:C) 
caused the same effects as were observed when cells were exposed to Comp-DEP. These 
data indicate that the observed effects may be a consequence of both the particle and the 
adsorbed components acting together. Furthermore, DE with a low organic content, SRM 
2975, also did not elicit the same effects as the Comp-DEP. One possibility is that the 
particle provides the adsorbed components with a route of entry into the cell. In fact, 
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previous studies have shown that respiratory epithelial cells can internalize these particles 
(133). When organic material from DEPs is not adsorbed onto a particle it may be unable to 
penetrate the cell and elicit the same effects as it would when it gains entry via cellular 
uptake of DEPs. Another possibility is that inorganic components of DE are responsible for 
the observe effects. Further studies will be needed to determine what components of DE are 
responsible for eliciting certain effects and responses in the cell and how different types of 
diesel engines running conditions, as well as collection methods, will influence the levels of 
these chemical components.  
Since epidemiological evidence has noted an association between exposure to ambient 
particulate matter and pulmonary infections (166), including exacerbation of respiratory 
symptoms associated with infection (29, 58, 155), the results presented here combined with 
previous findings in our laboratory (85) provide a potential mechanism by which exposure to 
particulate air pollutants, such as DE, enhances the susceptibility to respiratory virus 
infections. It will be of great interest and public concern to elucidate further mechanisms 
involved in these processes as well as to identify the effects of air pollutants on other aspects 
of host defense responses against respiratory viruses. 
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Figure 2  Localization of TLR3   
a) Surface and cytoplasmic staining for IgG and TLR3 was performed in A549 cells.  
Levels of TLR3 were measured using flow cytometry and compared to IgG for control.  
b) A549 cells were immunohistochemically stained for TLR3 (FITC) and nuclei were 
counterstained with DAPI.  Immunofluorescence was visualized using confocal 
microscopy.   
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 Figure 3  Effect of DEas and Influenza A on TLR3 mRNA levels   
Changes in mRNA were measured 24 hours after infection with Influenza A.  
Differentiated (a) nasal or (b) bronchial epithelial cells were treated with 0 or 44 
µg/cm2 of DEas for 2 hours prior to infection with 320 HAU/105 cells of Influenza 
A.  TLR3 mRNA was quantified using real time RT-PCR.  Values are normalized
to GAPDH mRNA. * significantly different from influenza infected cells, # 
significantly different from media control; p<0.05.    
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Figure 4.  Effect of DEas and poly(I:C) on TLR3 levels   
Changes in mRNA were measured 24 hours after stimulation with poly(I:C).   
 (a) A549 cells were treated with 0 or 25 µg/cm2 of DEas 2 hours prior to stimulation with 
100µg/ml of poly(I:C).  TLR3 mRNA was quantified using real time RT-PCR.  Values are 
normalized to GAPDH mRNA.  * significantly different from all other groups; p<0.01.  
(b)  Whole cell lysates prepared from A549 cells treated with 0 or 25 µg/cm2 of DEas prior 
to stimulation with 100 µg/ml poly(I:C) were analyzed for TLR3 protein levels. 
Nitrocellulose membranes were stripped and re-probed with anti-β-actin antibody. Optical 
densitometry readings for TLR3 were normalized to β-actin levels and shown as fold 
induction over the media control (numbers on top) to facilitate comparison. 
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Figure 5  Effect of DEas on IL-6 levels 
Changes in IL-6 mRNA (a) and protein (b) levels were measured 24 hours after 
stimulation with poly(I:C).  A549 cells were treated with 0 or 25 µg/cm2 of DEas 2 hours 
prior to stimulation with 100µg/ml of poly(I:C). IL-6 mRNA was quantified using real 
time RT-PCR and values were normalized to GAPDH mRNA.  IL-6 protein levels were 
measured in cellular supernatants by ELISA. * significantly different from all groups; 
p<0.01. # significantly different from media control; p<0.05.  
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Figure 6  Effect of dnTRAF6 on DEas-induced effects on IL-6 levels 
A549 cells were stably transduced with a control vector or a truncated form of 
TRAF6 (dnTRAF6) and treated with 0 or 25 µg/cm2 of DEas 2 hours prior to 
stimulation with 100µg/ml of poly(I:C).  Changes in IL-6 mRNA levels were 
measured 24 hours after stimulation with poly(I:C) using real-time RT-PCR.  
Values were normalized to GAPDH mRNA. # significantly different from 
media control; p<0.001, @ significantly different from dnTRAF6-DEas + p(I:C) 
group; p<0.05.    
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Figure 7  Effect of DEas on IFN-β transcription 
A549 cells were treated with 0 or 25 µg/cm2 of DEas 2 hours prior to stimulation 
with 100 µg/ml poly(I:C). (a) Changes in IFN-β mRNA levels were measured 24 
hours after stimulation with poly(I:C). IFN-β mRNA was quantified using real time 
RT-PCR and values were normalized to GAPDH mRNA. * significantly different 
from all other groups; p<0.05  (b) Nuclear extracts prepared 4 hours after 
stimulation with poly (I:C) were examined for IRF3 levels by Western blotting. 
Representative immunoblot for nuclear IRF3. 
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 Figure 8   Effect of DEas on levels of activated AKT and its role in IFN-β transcription 
(a) Changes in mRNA were measured 24 hours after stimulation with poly(I:C).  A549 cells 
were treated with DMSO or 1µM wortmannin for 30 min prior to treatment with 0 or 25 
µg/cm2 of DEas.   2 hours after treatment with DEas cells were stimulated with 100 µg/ml 
poly(I:C).  IFN-β mRNA was quantified using real time RT-PCR and values were 
normalized to GAPDH mRNA.  Values are expressed as fold induction over the respective 
media control. * significantly different from control; p<0.05. (b) Whole cell lysates prepared 
from A549 cells 1 hour after treatment with 0 or 25 µg/cm2 of DEas or stimulation with 
poly(I:C) were analyzed for levels of phosphorylated Akt. Nitrocellulose membranes were 
stripped and re-probed using an anti-Akt antibody. Representative immunoblots for 
phosphorylated (top) and total (bottom) Akt.  
Figure 9 Effect of PM on PRR mRNA 
expression.  Changes in mRNA  were measured 
24 hrs. after stimulation with poly(I:C) and data 
expressed as fold induction over media control. 
A549 cells were treated with 0 or 25µg/cm2 of 
PM 2 hrs. prior to stimulation with 100µg/ml of 
poly(I:C). TLR3 (a), RIG-I (b), and PKR (c) 
mRNA were quantified using real time RT-PCR.  
*significantly different from control; p<0.05  
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Figure 10  Effect of PM on cytokine mRNA expression. 
Changes in mRNA  were measured 24 hrs. after stimulation with poly(I:C) and data 
expressed as fold induction over media control. A549 cells were treated with 0 or 25µg/cm2 
of PM 2 hrs. prior to stimulation with 100µg/ml of poly(I:C). IL-6 (a), IL-8 (b), RANTES 
(c), and IFN-β (d) mRNA were quantified using real time RT-PCR.  *significantly different 
from control; p<0.05  
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Figure 11.  Effect EOM on TLR3 and IL-6 mRNA expression. 
  Changes in mRNA  were measured 24 hrs. after stimulation with poly(I:C). A549 cells  
were treated with a dose of EOM that would be equivalent to the amount of organic material 
from a 25µg/cm2 exposure of Comp. DEP. Cells were treated with EOM for 2 hrs. prior to 
stimulation with 100µg/ml of poly(I:C). TLR3 (a) and IL-6 (b) mRNA were quantified using 
real time RT-PCR.   
Media DMSO
EOM of Comp. DEP
MSHD UF Carbon SRM 2975 Comp. DEP  
alone poly(I:C) alone poly(I:C) alone poly(I:C) alone poly(I:C)
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RIG-I         
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IL-6         
IL-8         
RANTES         
IFN-β         
 
Summary of Effects
Table 1. Summary of Effects of different particulate preparations 
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 Figure 12. Effect of siRNA on 
antiviral responses 
Changes in mRNA were 
quantified in A549 cells using 
real-time RT-PCR. (a) Changes in 
MxA mRNA were quantified 24 
hrs after transfection with siRNA. 
Changes in HA RNA (b) and IL 
mRNA (c) were quantified 24 hrs. 
after infection with influenza 
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Chapter 3 
Diesel Exhaust Enhanced Susceptibility to Influenza Infection is Associated with 
Decreased Surfactant Protein Expression 
 
 
Introduction 
Diesel exhaust (DE) is an important contributor to particulate air pollution in urban air 
(42, 234). Combustion of diesel fuel generates a mixture of hundreds of organic and 
inorganic compounds in both the gas and particle phase, and more than 40 of the compounds 
in DE are listed by the United States Environmental Protection Agency (U.S. E.P.A) as 
hazardous air pollutants (HAPs) (235). DE particles (DEPs) are made up of an elemental 
carbon core that behaves as an adsorbtive surface onto which a multitude of organic chemical 
and metals bind.  Diesel exhaust particles are typically emitted as a mono-dispersed aerosol 
of around 0.2 µm (Mass median aerodynamic diameter [MMAD]) and may grow or 
accumulate up to around 1 µm in the atmosphere. These particles are thus easily respirable 
and capable of being deposited in the lower airways and alveolar region of the lung (116).  
Animal and human in vitro and in vivo studies have shown that exposure to DE increases 
neutrophil recruitment, nitric oxide production, and production of pro-inflammatory 
cytokines (76, 93, 148, 150, 178, 183).    
Exposure to DE has been shown to have adverse effects on host immune responses. Both 
human and animal experiments have demonstrated that DEPs can act as immunologic 
adjuvants by increasing allergen specific IgE and the production of Th2 cytokines (44, 56, 
238). Additionally, numerous studies have reported that DE increases susceptibility to 
respiratory infections. For example, several studies have demonstrated that DEP decreases 
phagocytosis and clearance of both gram negative and gram positive bacteria (28, 181, 214, 
256, 258).  In addition, reports by our laboratory as well as others’ have shown that exposure 
to DE can increase susceptibility to respiratory virus infections, such as influenza and 
respiratory syncytial viruses (RSV) (69, 71, 85).  
Influenza infections in the USA account for approximately 36,000 deaths and over 
100,000 hospitalizations each year, despite large-scale vaccination and antiviral treatments 
(226, 227). The virus replicates primarily in the epithelial cells of the respiratory tract, but 
can also infect macrophages and monocytes. Epithelial cells recognize viral pathogens 
through receptors including Toll-like receptor (TLR) 3, TLR 7, and retinoic acid–inducible 
protein I (RIG-I), whose activation leads to the expression of Type I interferons (IFNs) and 
inflammatory cytokines such as regulated upon activation, normal T-cell expressed, and 
secreted (RANTES), interleukin (IL)-6, IL-8, and tumor necrosis factor alpha (TNF-α). 
These cytokines recruit and activate immune cells, which ultimately clear the influenza 
infection. In addition, other innate immune defenses of the lung, such as calcium-dependent 
collagen-like lectins (collectins) bind and facilitate the phagocytosis of influenza, thereby 
inhibiting it from attaching and infecting pulmonary cells (13, 72). Surfactant proteins (SP), 
which are members of the collectin family, are part of the IFN-independent defense against 
influenza as well as other respiratory infections. SP-A and SP-D are secreted by alveolar type 
II cells and non-ciliated bronchial epithelial cells (clara cells) in the lung (124, 125). Previous 
studies have shown that uptake and clearance of Influenza A is reduced in SP-A- and SP-D-
deficient mice (113). Furthermore, mice exposed to DE had an increased susceptibility to 
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RSV infection, and this effect was associated with decreased expression of SP-A in the lungs 
(71). 
Given our previous findings, which demonstrated that exposure of respiratory epithelial 
cells to DE increases the susceptibility to influenza infections in vitro, we sought to confirm 
and expand upon these results using an in vivo murine model of DE exposure and subsequent 
influenza infection. Specifically, we analyzed whether repeated exposures to DE would 
increase the susceptibility to influenza infection and examined potential mechanisms 
mediating this effect. Our results demonstrate that repeated exposure to DE increases the 
susceptibility to influenza infections in mice and this was associated with increased lung 
inflammatory cytokine levels. In addition, repeated exposures to DE decreased the 
expression of SP-A and SP-D in the lung, suggesting a potential mechanism for the observed 
effect.  
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Materials and Methods 
Animals 
Pathogen- free BALB/c female mice, 10-12 wk old, weighing 17-20 g, were purchased from 
Charles River (Raleigh, NC).  All of the animals were housed in AAALAC-approved animal 
facilities with high-efficiency particulate air filters and received access to food and water ad 
libitum. The studies were conducted after approval by the laboratory’s Institutional Animal 
Care and Welfare Committee. 
Diesel Exhaust Exposure and Monitoring 
Diesel exhaust for exposure experiments was generated using a 30 kW (40 hp) 4-cylinder 
Deutz BF4M1008 diesel engine connected to a 22.3 kW Saylor Bell air compressor to 
provide a load.  The engine and compressor were operated at steady-state to produce 0.8 
m3/min of compressed air at 400 kPa. This translates to approximately 20% of the engine’s 
full-load rating. From the engine exhaust, a small portion of the flow (14 L/min) was educted 
by an aspirator (3:1 dilution) to a second cone diluter (10:1 dilution), and then through 
approximately 15 m of flexible food grade polyvinyl chloride (PVC) tubing (7.62 cm inside 
diameter) to two stainless steel 0.3 m3 Hinners inhalation exposure chambers housed in an 
isolated animal exposure room.  The dilution air used was drawn from the animal exposure 
room through a high efficiency particulate air (HEPA) filter.  Target DEP concentrations in 
the two chambers were 2000 µg/m3 (high) and 500 µg/m3 (low). Control animals were 
housed in a third chamber supplied with the same HEPA filtered room air. DEP 
concentrations in the low (500 µg/m3) chamber were achieved by additional dilution using 
HEPA filtered room air just prior to entering the chamber. All three chambers were operated 
at the same flow rate (142 L/min), which resulted in 28 full air exchanges per hour. 
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Integrated 4 h filter samples (14.1 L/min) were collected daily from each chamber and 
analyzed gravimetrically to determine particle concentrations.  In addition, 8 and 20 min 
quartz filter samples (14.1 L/min) were collected from the high and low chambers 
respectively, to determine organic carbon/elemental carbon (OC/EC) partitioning of the 
collected DEP. Continuous emission monitors (CEMs) were used to measure chamber 
concentrations of PM by tapered element oscillating microbalance, (TEOM, TSI Inc., St 
Paul, MN), oxygen (O2, Beckman, La Habra, CA), carbon monoxide (CO, Thermo Electron 
Corp, Waltham, MA), nitric oxide (NO, Thermo Electron Corp, Waltham, MA), nitric 
dioxide (NO2, Thermo Electron Corp, Waltham, MA), sulfur dioxide (SO2, Thermo Electron 
Corp, Waltham, MA), and total hydrocarbons (THC, California Analytical, Orange, CA). 
Samples were extracted through fixed stainless steel probes in the exposure chambers. Gas 
samples, with the exception of THC, were passed through a particulate filter prior to the 
individual gas analyzers. Dilution air was adjusted periodically to maintain target PM 
concentrations as measured by the TEOM.  Particle size distributions were characterized 
using a TSI Inc. (St. Paul, MN) scanning mobility particle sizer (SMPS) and aerodynamic 
particle sizer (APS).  
Average concentrations (and standard deviations) for the CEM measurements from both 
PM chambers are presented in Table 2. Chamber temperatures, relative humidity, and noise 
were also monitored, and maintained within acceptable ranges. Mice were exposed to HEPA 
filtered room air or to 0.5, or 2.0 mg/m3 DEP 4 h/day for 5 consecutive days. 
Oropharyngeal Aspiration of Virus 
Immediately after the last DE exposure mice were anesthetized in a small Plexiglass box 
using vaporized isofluorane (Webster Veterinary Supply Inc., Sterling, MA). The needle 
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used for intratracheal injections was a 24 –gauge intragastric feeding needle, with a 1.25 mm-
diameter ball on tip, attached to a 1 ml syringe. The mice were then suspended vertically by 
their front incisors on a small wire attached to a support. The tongue was extended with 
forceps and 50 µl of either sterile saline (Hospira Inc., Lake Forest, IL) or 10 
hemagglutination units (HAU) of influenza A/Bangkok/1/79 (H3N2 serotype) in 50 µl of 
saline was instilled into the oro-pharynx.  The nose of the mouse was then covered, causing 
the liquid to be aspirated into the lungs. 
Influenza Virus 
The influenza A/Bangkok/1/79 (H3N2 serotype) used in this study was obtained from Dr. 
Melinda Beck (Dept. of Nutrition, University of North Carolina, Chapel Hill, NC 27514). 
The virus was propagated in 10-day-old embryonated hen’s eggs.  The virus was collected in 
the allantoic fluid and titered by 50% tissue culture infectious dose in Madin-Darby canine 
kidney cells and hemagglutination as previously described (11).  Stock virus was aliquoted 
and stored at -80◦ C until use.  Each mouse was infected with 10 HAU diluted in sterile saline 
by intratracheal instillation as described above. 
Bronchoalveolar Lavage  
Eighteen hours post infection, mice from each treatment group (n = 5-11) were euthanized 
with sodium pentobarbital and the trachea was exposed, cannulated, and secured with suture 
thread.  The left mainstem bronchus was isolated, clamped with alligator clips after the 
trachea was cannulated. The right lungs lobes were lavaged 3 times with three volumes of 
warmed Hanks balanced salt solution (HBSS) (Invitrogen, Grand Island, NY) (35ml/kg). The 
resulting lavage was centrifuged (717 x g, 15 min, 4◦ C) and 150 µl was stored at 4◦ C (for 
biochemical analysis) or -80◦ C (for cytokine measurement). The pelleted cells were 
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resuspended in 1 ml of RPMI 1640 (Gibco, Carlsbad, CA) containing 2.5 % fetal bovine 
serum (FBS; Gibco, Carlsbad, CA). Total cell counts in the lavage fluid of each mouse were 
obtained with a Coulter Counter (Beckman Dickson).  Each sample (200 µl) was centrifuged 
in duplicate onto slides using a Cytospin (Shandon, Pittsburgh, PA) and subsequently stained 
with Diff Quik solution (American Scientific, McGraw Park, PA) for cell differentiation 
determination, with at least 200 cells counted from each slide.  The left lobe was then 
removed for RNA, protein isolation, or immunohistochemistry. 
Cytokine Measurements 
IL-6 concentrations in bronchoalveolar lavage (BAL) were measured by enzyme-linked 
immunosorbent assay (ELISA) with commercially available paired antibodies per 
manufacturer’s instructions (Pharmingen, Franklin Lakes, NJ). 
BAL fluid Biochemistry 
Total protein, microalbumin (MIA), and N-Acetyl-B-D-glucosaminidase (NAG) were 
modified for use on the Konelab 30 clinical chemistry analyzer (Thermo Clinical Labsystems 
Espoo, Finland). Total protein concentrations were determined with the Coomassie plus 
protein Reagent (Pierce Chemical, Rockford, IL) with a standard curve prepared with bovine 
serum albumin from Sigma-Aldrich (St. Louis, MO.).  Microalbumin concentrations were 
determined with the MALB SPQ II kit (Diasorin, Stillwater, MN).  NAG activity was 
determined from a commercially available kit from Roche Diagnostics (Pemzberg, 
Germany). 
Western Blotting 
Lung homogenates were prepared by homogenizing the tissue in 1x lysis buffer (Cell 
Signalling, Danvers, MA) containing protease inhibitors (Roche Diagnostics, Pemzberg, 
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Germany). Lung homogenates (10 µg) were separated by electrophoresis using a10% bis-tris 
gels under reducing conditions (Invitrogen, Grand Island, NY). This was followed by 
immunoblotting using specific antibodies to Surfactant Protein A (1:2000; Chemicon, 
Temecula, CA) or Surfactant Protein D (1:100; Chemicon, Temecula, CA).  β-actin was used 
as a loading control for SP-A and SP-D (1:2000; US Biological, Swampscott, MA).  
Antigen-antibody complexes were stained with anti-goat or anti-mouse horseradish 
peroxidase-conjugated antibody (1:2000; Santa Cruz Biotechnology, Santa Cruz, CA) and 
SuperSignal West Pico chemiluminescent substrate (Pierce, Rockford, IL).  
Chemiluminescent signals were acquired using an Alpha Innotech 8900 imaging station (San 
Leandro, CA) and visualized using Fluorchem software (Alpha Innotech, San Leandro, CA). 
Densitometric analysis of optical densities was performed using software (Alpha Ease FC, 
San Leandro, CA).   
Real Time PCR 
Total RNA was extracted with TRIzol (Invitrogen, Grand Island, NY) as per the supplier’s 
instructions.  First strand cDNA synthesis and real-time RT-PCR were performed as 
previously described (86, 87).  The sequences for the primers and probes used in this study 
are as follow: HA: probe 5’-FAM-TGATGGGAAAAACTGCACACTGATAGATGC-
TAMARA-3’; sense 5’- CGACAGTCCTCACCGAATCC- 3’; antisense 5’- 
TCACAATGAGGGTCTCCCAATAG -3’; IL-6: probe 5’-FAM-
CCAGCATCAGTCCCAAGAAGGCAACT-TAMRA-3’; sense 5’-
TATGAAGTTCCTCTCTGCAAGAGA-3’; antisense 5’-TAGGGAAGGCCGTGGTT-3’; 
IFN-α: probe 5’-FAM-CTGCATCAGACAGCCTTGCAGGTCATT-TAMRA-3’; sense 5’-
TGCAACCCTCCTAGACTCATTCT-3’; antisense 5’-CCAGCAGGGCGTCTTCCT-3’; 
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IFN-β: probe 5’-FAM-AGGGCGGACTTCAAGATCCCTATGGA-TAMRA-3’; sense 5’-
TGAATGGAAAGATCAACCTCACCTA-3’; antisense 5’-
CTCTTCTGCATCTTCTCCGTCA-3’; INF-γ: probe 5’-FAM-
CCTCAAACTTGGCAATACTCATGAATGCATCC-TAMRA-3’; sense 5’-
AGCAACAGCAAGGCGAAAA-3’; antisense 5’-CTGGACCTGTGGGTTGTTGA-3’. The 
mRNA analyses for SP-A and SP-D were performed using commercially available 
primer/probe sets (inventoried Taqman® Gene Expression Assays) purchased from Applied 
Biosystems (Foster City, CA). 
Immunohistochemistry 
Lung tissue samples were fixed in 4% paraformaldhyde and embedded in paraffin.  Five µm 
thick sections were placed on Superfrost/plus slides (Fisher Scientific) and stained for 
nucleoprotein of influenza A (clone IA52.9, 1:40; Argene, Varilhes, France), SP-A (1:4000; 
Chemicon, Temecula, CA), or SP-D (1:200; Chemicon, Temecula, CA).  A no primary 
control was also performed for each protein. The slides were evaluated under light 
microscopy.  
Statistical Analysis 
Data were pooled from three replicate experiments and are expressed as means ± SEM of 
three separate experiments.  Data were analyzed using a nonparametric one-way ANOVA 
(Kruskal-Wallis test), followed by the Dunn’s multiple comparison post hoc test. A value of 
P<0.05 was considered to be significant. 
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Results 
Exposure to DE enhances the susceptibility to influenza infection 
 The first objective of this study was to determine if repeated exposure of mice to DE 
under the described conditions would also enhance the susceptibility to infection with 
Influenza A. To do this, RNA levels of hemagglutinin (HA), a marker of viral proliferation, 
in whole lung homogenates were measured 18 hours post-infection using real-time RT-PCR. 
Figure 13A shows that mice exposed to 0.5 mg/m3 of DE had significantly greater levels of 
HA mRNA compared to air exposed mice. HA levels were not significantly altered in mice 
exposed to 2.0 mg/m3 of DE. To confirm this effect, lung sections were 
immunohistochemically stained for influenza using indirect immunofluorescence and 
visualized using epifluorescence microscopy. Figure 13B shows influenza staining in the 
airways of mice exposed to air or DE. Mice exposed to the low dose of DE show increased 
influenza staining, confirming the mRNA data. Thus, enhanced susceptibility to influenza 
infection following the low dose of DE exposure is illustrated by the increases in both HA 
mRNA and influenza staining observed in the lungs of mice.  
Exposure to diesel exhaust increases the influenza-induced inflammatory response 
 Cells infected with influenza respond by releasing various cytokines and chemokines to 
aid in fighting the invading pathogen. The purpose of many of these mediators released by 
the infected cell is to recruit and activate inflammatory cells. Given the effect of DE on the 
susceptibility to influenza infection, the next objective was to determine what effect DE had 
on pro-inflammatory mediator production in influenza-infected animals. Eighteen hours post-
infection, the expression of IL-6 was analyzed. Levels of IL-6 expression were quantified in 
whole lung homogenates using real-time RT-PCR and protein levels were measured in the 
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BAL fluid by ELISA (Figure 14).  Figure 14A shows that levels of IL-6 mRNA were 
significantly greater in the lungs of mice exposed to 0.5 mg/m3 of DE prior to infection 
compared to mice exposed to air. Similarly, there was a significantly greater amount of IL-6 
protein in the BAL fluid of these animals compared to air exposed controls (Figure 14B). 
Exposure to DE in the absence of influenza infection had no significant effect on IL-6 
mRNA or protein levels. Taken together, these data show that in addition to enhanced 
susceptibility to influenza infection, DE also increased the virus-induced inflammatory 
response.  
Exposure to DE does not increase pulmonary injury 
 Since levels of the pro-inflammatory mediator IL-6, was increased in mice exposed to DE 
prior to infection, it was important to determine if there was also an increase in inflammatory 
cell infiltration into the lungs as well as increased lung injury resulting from the enhanced 
inflammatory response. The number of total cells in the BAL fluid of mice was quantified by 
coulter counter (table 3) in addition to differential cell counts to quantify levels of 
macrophages (table 3) and  polymorphonuclear cells (PMNs) (fig 15A) in the BAL fluid 18 
hours post-infection. As expected, Figure 15A shows that infection with influenza virus 
increases the levels of PMN in the BAL fluid. However, exposure to either dose of DE prior 
to infection had no statistically significant effects on the levels of BAL fluid PMNs. 
Surprisingly, exposure to DE alone had no effect on the levels of PMNs in the BAL fluid (fig 
15A). Levels of protein in the BAL fluid, a marker of edema, were determined 18 hours post-
infection. Neither exposure to DE nor infection with influenza significantly increased BAL 
fluid protein levels as compared to air exposed non-infected mice (fig 15B). Similarly, other 
markers of injury, such as NAG and MIA were not significantly affected by either DE 
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exposure or influenza virus infections (Table 3). These results show that the increase in 
PMNs caused by influenza infection were not accompanied by an increase in pulmonary 
injury and although exposure to DE prior to infection with influenza increases susceptibility 
to viral infection and pro-inflammatory mediator production, the exposure regimen used here 
does not result in significant increase in inflammatory cell recruitment or pulmonary injury 
18 hours post-infection. 
Effect of DE on the influenza-induced upregulation of TLR3 
 We have previously observed a significant increase in TLR3 mRNA expression in 
respiratory epithelial cells exposed to DE prior to infection with influenza (31). Therefore, 
the next objective was to determine the effect of DE exposure on TLR3 expression. To 
determine if exposure to DE prior to influenza infection would increase the expression of 
TLR3 in vivo, levels of TLR3 mRNA were quantified 18 hours post-infection in whole lung 
homogenates using real-time RT-PCR. Figure 16A shows that infection with influenza 
caused a significant increase in TLR3 mRNA levels in the lungs of mice exposed to air or 0.5 
mg/m3 DE, but not in mice exposed to 2.0 mg/m3 DE. DE exposure did not significantly 
enhance TLR3 mRNA expression in response to infection. To confirm and expand upon 
these results lung sections were immunohistochemically stained for TLR3 (figure 16B). The 
left panel shows that there is no change in TLR3 staining observed in the airways, while the 
right panel suggests that there is increased TLR3 expression in the alveolar region of the 
lungs of mice exposed to 0.5 mg/m3 DE prior to infection.  
The enhanced susceptibility to infection caused by exposure to DE is not due to a decreased 
antiviral response 
 
 Hahon et al. have shown that mice repeatedly exposed to DE particulate for 6 months had 
a decreased ability to produce interferon in response to influenza infection as well as 
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increased viral multiplication (69). Therefore, it seemed likely that the increased viral load 
observed in the lungs of our DE-exposed mice was due to a decrease in interferon production 
and possibly other antiviral mediators. To investigate this, levels of interferon (IFN)-α, IFN-
β, and IFN-γ mRNA were quantified 18 hours post-infection in whole lung homogenates 
using real-time RT-PCR. There was no significant change in IFN-α mRNA levels at either 
dose of DE (Figure 17A), however, mice exposed to 0.5 mg/m3 of DE prior to infection had 
significantly greater levels of IFN-β mRNA compared to air controls (Figure 17B). Similarly, 
IFN-γ mRNA levels were elevated, albeit not significantly, in mice exposed to 0.5 mg/m3 of 
DE prior to infection with influenza (Figure 17C) compared to controls. There was no effect 
on any of the IFNs observed in uninfected mice exposed to DE (data not shown).   
The DE-induced effects on the susceptibility to infection are associated with changes in the 
expression of surfactant proteins 
 
 Since the enhanced susceptibility to infection observed in animals exposed to the 0.5 
mg/m3 dose of DE could not be explained by a decreased interferon response, the next 
objective was to examine the expression of interferon-independent antiviral defense 
molecules, such as surfactant proteins (SP) in the lung. Levels of SP-A mRNA in whole lung 
homogenates were quantified 18 hours post-infection by real-time RT-PCR. Influenza virus 
infection alone significantly increased the expression of SP-A in the lung in mice exposed to 
air (Figure 18A). Mice, exposed to 0.5 mg/m3 of DE prior to infection had a significant 
decrease in the levels of SP-A mRNA in the lungs, which was not observed in mice exposed 
to 2.0 mg/m3 DE prior to infection. To determine if these effects also occurred at the protein 
level expression of SP-A protein was analyzed in whole lung homogenates by western 
blotting. Figure 18B shows that there was a decreased expression of SP-A protein in the 
lungs of mice exposed to 0.5 mg/m3 of DE prior to infection. Localization of SP-A in lung 
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sections following immunohistochemical staining showed that air exposed mice infected with 
virus strongly expressed SPA in the alveolar region. This expression was decreased in mice 
exposed to 0.5 mg/m3 of DE prior to infection, but not in the mice pre-exposed to 2.0 mg/m3 
(fig 18C).  
In addition to SP-A, pulmonary expression of SP-D was also examined. Levels of SP-D 
mRNA in whole lung homogenates were quantified 18 hours post-infection using real-time 
RT-PCR. Similar to SP-A, levels of SP-D mRNA and protein were significantly decreased in 
the lungs of mice exposed to 0.5 mg/m3 of DE prior to infection compared with mice 
exposed to air or 2.0 mg/m3 DE prior to infection (figures 19A and 19B). 
Immunohistochemical analysis (Figure 19C) showed that in mice exposed to air prior to 
infection with influenza SP-D localized in the alveolar region (left panels) and airways (right 
panels). Similar to SP-A and confirming the observations made in figure 19A and 19, Figure 
19C demonstrates that exposure to 0.5 mg/m3 of DE prior to infection with influenza 
decreased levels of SP-D, especially in the airways, while mice exposed to 2.0 mg/m3 of DE 
prior to infection showed no significant difference as compared to the air-exposed mice. 
Taken together these data suggest a strong association between enhanced susceptibility to 
infection observed in mice exposed to 0.5 mg/m3 of DE and decreased expression of SP-A 
and SP-D in these animals.  
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Discussion 
Various reports have linked DE to adverse effects on host immunity. Specifically, studies 
by us and others have shown that in vitro exposure of human respiratory epithelial cells and 
repeated in vivo exposure of mice to DE increases the susceptibility to respiratory viral 
infections (28, 69, 71, 85). Given these findings, this study was designed to elucidate 
potential mechanisms by which exposure to DE enhances the susceptibility to infection with 
influenza virus in vivo. The overall hypothesis for the study was that prior exposure of mice 
to DE would enhance the susceptibility to influenza infection via suppression of innate 
immune defenses of the host. The results obtained in this study demonstrate that repeated 
exposure of mice to 0.5 mg/m3 of DE enhances the susceptibility to Influenza A infections 
and that these effects were linked with increased influenza-induced expression of IL-6 and 
IFN-ß. Interestingly, exposure of mice to 2.0 mg/m3 of DE did not enhance the susceptibility 
to Influenza A infections. The DE-enhanced susceptibility to influenza virus infections was 
strongly associated with decreased expression of SP-A and SP-D in the lung, suggesting that 
modification of surfactant protein levels presents a potential mechanism for the effect of DE 
exposure on influenza virus infections.  
 Pulmonary cells employ various antiviral defense strategies to combat respiratory 
pathogens. Surfactant proteins (SP), which are members of the collectin family, belong to the 
IFN-independent defense responses. As stated earlier, SP-A and SP-D are secreted by 
alveolar type II cells and nonciliated bronchial epithelial cells, also known as clara cells, in 
the lung (124, 125).  These proteins contribute to the innate defense responses against 
influenza through their ability to bind and neutralize the virus (13, 72). Previous studies have 
shown that uptake and clearance of Influenza A is reduced in SP-A or SP-D deficient mice, 
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resulting in an increased inflammatory response (113).  It has also been demonstrated that 
exposure to air pollutants such as ozone and cigarette smoke decreases the expression or 
modulates the activity of pulmonary surfactant proteins (78, 242). In this study a significant 
decrease in mRNA and protein expression of both SP-A and SP-D was observed in the lungs 
of mice exposed to 0.5 mg/m3 of DE alone or prior to infection compared to mice exposed to 
air.  No change in expression was observed in either SP-A or SP-D levels in mice exposed to 
2.0 mg/m3 of DE, which was an exposure level that also did not increase susceptibility to 
influenza virus infections. Harrod et al. observed an enhanced susceptibility to RSV 
infections and a decrease in SP-A expression in mice sub-chronically exposed (6 hrs/day for 
7 days) to 0.03 or 1.0 mg/m3 of DE (71).  Despite the similarity in findings, this present study 
differs in certain aspects.  For instance an off road diesel engine was used to generate the DE 
for this study, whereas Harrod et al. employed an on-road diesel engine, which likely resulted 
in different chemical composition of the diesel engine emissions.  Furthermore, endpoints for 
this study were analyzed 18 hours post infection, which focuses entirely on the innate 
immune responses, whereas the analyses performed by Harrod et al. were 4 days post 
infection that would be during the development of specific immune responses.  Despite their 
differences, these studies show that DE can affect the production of essential clearance 
mechanisms therefore increasing the susceptibility to respiratory viral infections. However, 
the mechanism whereby DE exerts its effect on surfactant protein expression is still 
unknown. One possibility is that SP expression is affected indirectly by DE, involving 
upstream signaling proteins that play a role in the transcriptional regulation of surfactant 
proteins. Previous studies have shown that the transcription factor NFAT (nuclear factor of 
activated T cells) regulates both SP-A and SP-D gene transcription (38, 39), and NFAT in 
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turn is negatively regulated by Akt (259). Previous studies in our laboratory have shown that 
exposure of respiratory epithelial cells to DE results in an increased expression of activated 
Akt (31). Thus, DE-induced activation of Akt may result in increased inhibition of NFAT, 
thus decreasing the transcriptional activation of SP-A and SP-D.  
 In addition to influenza and RSV, SP-A and SP-D are also essential for the clearance of 
other respiratory pathogens such as group B Streptococcus (GBS), Haemophilus influenza, 
and Pseudomonas aeruginosa (107, 111, 112).  Animal models deficient in either of these 
collectins have a significant increase in pro-inflammatory cytokines such as IL-6 and TNF-α, 
an increase in NFκB activation, as well as an increase in superoxide production after 
microbial challenge (107, 111, 112, 260). Furthermore, studies have shown that decreased 
expression of SP-A and SP-D are associated with pulmonary disease states such as cystic 
fibrosis, acute interstitial pneumonias (ARDS) (64, 169, 244). Taken together, these data 
demonstrate how a DE-induced decrease in SP expression could impact host immunity.  
 In addition to the enhanced susceptibility to infection and decrease in SP-A and SP-D 
expression observed, there was also an increase in the influenza-induced production of the 
pro-inflammatory mediator IL-6 observed in mice exposed to DE prior to infection.  Levels 
of IL-6 mRNA and protein were significantly greater in mice exposed to the low dose of DE 
prior to infection with influenza. Similar results were obtained in the study by Harrod et al., 
which examined the effects of repeated DE exposures on the susceptibility and response to 
respiratory syncytial virus (RSV) infection. Mice exposed to 1.0 mg/m3 of DE for 7 days 
were more susceptible to RSV infection and mounted a greater inflammatory response to 
infection (71).  Inflammatory mediators are produced by infected cells to orchestrate an 
antiviral defense response aimed at clearing the invading pathogen. However, excessive 
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inflammation is detrimental to the host, causing tissue injury and increasing the morbidity of 
a respiratory infection. Given the increase in IL-6 it was necessary to determine if this effect 
was associated with inflammatory cell recruitment and tissue injury. As expected, influenza 
infection increased the level of PMNs in the BAL fluid. However, exposure to either low or 
high level of DE did not further enhance influenza-induced PMN influx. In addition, no 
changes in BAL fluid protein levels or other markers of injury were observed in mice 
exposed to either dose of DE prior to infection. Previous studies have demonstrated that 
levels of BAL fluid protein and other markers of injury in influenza-infected mice do not 
increase until about 3 days post-infection and peak even later than that (16, 103). Thus, it is 
reasonable to speculate that although no significant effects of DE on influenza-induced lung 
injury were observed at the timepoint included in this study (18 hrs p.i.), it is still possible 
that increases in PMN influx and pulmonary injury may result at later timepoints post-
infection. Further studies are currently underway to examine the effects of DE at markers of 
injury and adaptive immune responses occurring at later time points during the course of an 
influenza infection.  
 Previous studies have demonstrated that chronic exposure of mice to DE resulted in an 
increased susceptibility to influenza infection, which was correlated with decreased lung IFN 
levels (69). These data suggest that suppression of the host’s IFN-dependent, innate antiviral 
response resulted in a reduced ability to limit and clear the invading pathogen. However, in 
the present study the enhanced influenza infection in mice exposed to 0.5 mg/m3 of DE was 
not associated with any decrease in IFN expression and in fact, levels of IFN-β mRNA were 
significantly greater in the lungs of mice exposed to 0.5 mg/m3 of DE and corresponded to 
the increased level of infection. These observations confirm our previous studies that 
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demonstrated that respiratory epithelial cells exposed to DE had increased susceptibility to 
influenza virus without affecting the expression of IFN-ß (85). The results are in accordance 
with previous studies, which reported that sub-chronic exposure of mice to DE resulted in an 
enhanced susceptibility to RSV infection, but did not decrease lung IFN levels (71).  
 Expression of pro-inflammatory cytokines and type I interferons in response to viral 
infection can result from TLR3 activation, through its recognition of dsRNA, and subsequent 
signaling (3, 132). As stated earlier, dsRNA is commonly produced during a viral infection. 
Our previous results demonstrated that exposure of respiratory epithelial cells to DE 
enhanced TLR3 expression and signaling in response to influenza infection (31). A small, 
although not significant, increase in TLR3 mRNA was observed in the lungs of mice exposed 
to 0.5 mg/m3 DE prior to infection. The lack of a significant increase in TLR3 mRNA may be 
due to the fact that the whole lung homogenates used to quantify levels of mRNA contain 
many cell types that have little or no expression of TLR3 as well as non-cellular material that 
is preventing us from detecting significant increases in certain cell types. It is possible that 
only certain cells are upregulating TLR3 in response to DE exposure and influenza infection. 
This notion is supported by the immunohistochemical staining for TLR3, which appears to 
show an increase in TLR3 expression in the alveolar region of the lung. Specifically, it 
appears that type II epithelial cells are the main cell type expressing TLR3. Further studies 
will be needed to determine how exposure to DE affects TLR3 expression in vivo. 
 Many of the endpoints examined in this study show an unusual biphasic response to the 2 
different exposure concentrations of DE. While there is no direct evidence to explain why 
this type of response was observed, there are several hypotheses that warrant further 
investigation.  One possible explanation for this observed effect is that exposure to the high 
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dose of DE causes an increase in iNOS expression, resulting in increased NO production. 
The virucidal activity of increased NO levels (35) could in turn create an antiviral 
environment within the lungs, resulting in less infectivity. This hypothesis is supported by a 
study conducted by Rao et al., which showed that instillation of rats with a high dose of 
DEPs, but not the low and mid doses, resulted in significantly greater levels of iNOS mRNA 
in lung cells obtained from the BAL fluid (171). Thus, high level of DE but not the low level 
of DE exposure applied here might result in increased NO, thus generating an unfavorable 
environment for a viral infection.  Another possible explanation is increased oxidative stress 
caused by exposure to the high levels of DE. Previous reports have suggested that exposure 
to DE induces a hierarchical oxidative stress response, with antioxidant defense responses 
and inflammatory responses induced by lower DE exposure levels and necrosis and apoptosis 
induced by higher levels of DE (253). While exposure to DE at a lower level leads to an 
inflammatory response, exposure to levels such as 2 mg/m3 DE may be a dose, which 
ultimately leads to cytotoxicity. Previous studies, including our own, have demonstrated that 
exposure to DEP results in a dose-dependent increase in oxidative stress as well as cell death 
and these studies propose that as oxidative stress increases there is a progression from 
inflammation to toxicity ultimately resulting in apoptosis or necrosis (85, 115, 116, 253). 
Interestingly, apoptosis in epithelial cells creates an environment, which is not conducive for 
infection and replication of influenza (reviewed in 7). Thus, apoptosis in epithelial cells 
induced by the high DE exposure level may prevent efficient infection and replication of 
influenza virus and therefore neutralize the enhancing effects of DE on influenza virus 
infection. Lastly, biphasic dose response patterns are not all unusual in immune responses 
(for review see 22). For example, in vitro exposure to DEP and phorbol 12-myristate 13-
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acetate (PMA) resulted in increased expression of IL-8 at lower doses of DEP, but a decrease 
in IL-8 expression was observed when cells were exposed to higher doses of DEP (236). 
Stanulis et al. showed that low doses of corticosterone resulted in an enhancement of the Th2 
cytokines, IL-4 and IL-10, whereas higher doses had a suppressive effect in mice (212). 
Taken together these as well as many others studies illustrate that a number of different 
immunological endpoints can display biphasic dose-responses caused by exposure to a 
variety of agents.  
 The data presented here provide further evidence that exposure to an air pollutant such as 
DE at levels which are seen in occupational settings, can enhance the susceptibility and 
response to respiratory viral infection through an alteration of the host’s innate immune 
defenses. By decreasing the expression of surfactant proteins, exposure to DE increases the 
likelihood of an individual becoming infected with influenza. The enhanced viral load 
associated with the increased inflammatory response may result in increased inflammatory 
cell recruitment, pulmonary injury, and changes in adaptive immune responses at later times 
during the course of an infection, which is currently the focus of another study in our 
laboratory. It will be of great interest and public concern to elucidate further conditions and 
mechanisms whereby DE can alter host susceptibility and response to respiratory viral 
infections as well as to identify effects on other aspects of host immunity. 
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Constituent Units Low High 
Particle mass mg/m3 0.529±0.008 2.07±0.03 
O2 % 20.87±0.06 20.54±0.07 
CO ppm 0.9±0.19 5.4±0.24 
NO2 ppm <0.25 1.13±0.04 
NO ppm <2.5 10.8±0.51 
SO2 ppm 0.06±0.02 0.32±0.1 
Table 2. Summary of exposure concentrations of particle mass and gases.   
Measurements shown are mean of three experiments ± SE.  Definition of abbreviations: O2, 
oxygen; CO, carbon monoxide; NO2, nitrogen dioxide; NO nitrogen oxide; SO2, sulfur dioxide. 
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Figure 13.  Effect of DE on the susceptibility to influenza infection. 
 a) Levels of HA mRNA were quantified in lung homogenates 18 hrs after infection 
with influenza by real-time RT-PCR. Values are normalized to β-actin and expressed as 
mean + SEM. *significantly different from air/influenza mice; p<0.05.  b) Mouse lung 
sections were immunohistochemically stained for influenza and visualized using 
confocal microscopy. 
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Figure 14. Effect of DE on the influenza-induced inflammatory response. 
Measurements were taken 18 hrs. post-infection and all data is expressed as mean + 
 SEM. a) Levels of IL-6 mRNA were quantified in lung homogenates by real-time 
RT-PCR and normalized to levels of β-actin. (b) Levels of IL-6 protein were 
quantified in the BAL fluid by ELISA. *significantly different from air/influenza 
mice; p<0.05.   
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Figure 15. Neutrophil recruitment and levels of protein in the BAL fluid. 
Measurements were taken 18 hrs. post-infection and all data expressed as mean + 
SEM. a) The number of neutrophils was determined by differential cell counts. (b)  
Levels of protein were quantified in the BAL fluid. *significantly different from 
indicated groups, # significantly different from all groups; p<0.05.  
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12.46 + 0.9320.52 + 3.8412.33 + 0.9512.56 + 0.8211.8 + 1.6113.07 + 1.09MIA (ug/ml)
7.57 + 1.15.3 + 0.285.65 + 0.465.22 + 0.175.20 + 0.286.30 + 0.57NAG (U/L)
4.6 + 0.84.8 + 0.75.9 + 1.15.9 + 0.66.9 + 1.313 + 2.2Macrophages (104)
19 + 3.516 + 3.314 + 3.46.9 + 0.87.8 + 1.314 + 2.3Total Cells (104)
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Table 3. Summary of cell counts and markers of injury 
Measurements were taken 18 hrs post-infection and all data expressed as mean. Total cell 
counts in the BAL fluid of each mouse were obtained with a Coulter Counter and number of 
macrophages was determined by differential cell counts.  BAL fluid MIA concentrations 
were determined with the MALB SPQ II kit and NAG activity was determined from a 
commercially available kit. 
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Figure 16. Effect of DE on TLR3 expression. 
a) Levels of TLR3 mRNA were quantified in lung homogenates 18 hrs after 
infection with influenza by real-time RT-PCR. Values are normalized to β-actin 
and expressed as mean + SEM. *significantly different uninfected mice; p<0.05.  
b) Mouse lung sections were immunohistochemically stained for TLR3 and 
visualized using confocal microscopy. Airway (left) and alveolar (right) regions 
are shown. Arrows denote positively stained cells.  
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Figure 17. Effect of DE on the influenza-
induced interferon response.  
Levels of IFN-α (a), IFN-β (b), and IFN-γ 
(c), mRNA were quantified in lung 
homogenates 18 hrs after infection with 
influenza by real-time RT-PCR. Values are 
normalized to β-actin and expressed as 
mean +
 
 
 
 
 
 
 
 SEM. *significantly different from 
air/influenza mice; p<0.05. 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 18. Effect of DE on SP-A expression.  
a) SP-A mRNA was quantified in lung 
homogenates 18 hrs after infection by real-time 
RT-PCR. Values are normalized to β-actin and 
expressed as mean + SEM. *significantly 
different from indicated group, # signifcantly 
different from air/influenza and 2.0mg/m3 
DE/influenza mice; p<0.05. b) Lung 
homogenates collected 18 hrs post-infection 
were analyzed for SP-A protein levels. 
Nitrocellulose membranes were stripped and re-
probed with anti-β-actin antibody. c) Mouse 
lung sections were immunohistochemically 
stained for SP-A and visualized using light 
microscopy; 40x magnification of airways (left 
panel) and 100x magnification of alveolar 
region (right panel).  
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Figure 19. Effect of DE on SP-D 
expression.  
a) SP-D mRNA was quantified in lung 
homogenates 18 hrs after infection by 
real-time RT-PCR. Values are 
normalized to β-actin and expressed as 
fold mean + SEM. # significantly 
different from air/influenza and 2.0 
mg/m3 DE/influenza mice; p<0.05. b) 
Lung homogenates collected 18 hrs post-
infection were analyzed for SP-D protein 
levels. Nitrocellulose membranes were 
stripped and re-probed with anti-β-actin 
antibody. c) Mouse alveolar (left panel) 
and airway (right panel) lung sections 
were immunohistochemically stained for 
SP-D and visualized using light 
microscopy.  
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Chapter 4 
Influenza-induced TLR3 Upregulation in Pulmonary Epithelial Cells Occurs through a 
Positive-feedback Loop Involving Type I Interferons and can be Enhanced by Exposure 
to Diesel Exhaust 
 
Introduction 
 The host’s first line of defense against an invading pathogen is the innate immune 
response. It activates the secondary immune response and keeps the infection under control 
until the adaptive response is mobilized. An integral role in the innate immune response is 
played by Toll-like receptors (TLRs). These receptors are members of the superfamily of 
interleukin-1 receptors (IL-1R) and share homology in the cytoplasmic region referred to as 
the Toll/IL-1R (TIR) domain (200). TLRs recognize conserved pathogen-associated 
molecular patterns (PAMPs) and binding of their respective ligands leads to the production 
of innate immune defense mediators as well as activation of the adaptive immune response 
(1, 2, 84). Toll-like receptor 3 (TLR3) recognizes double-stranded RNA (dsRNA), a 
molecular pattern commonly associated with viral infection. dsRNA stimulates TLR3 
signaling, which culminates in the activation of numerous downstream signaling proteins and 
transcription factors and ultimately results in the production of inflammatory cytokines and 
type I interferons (3, 67, 132).  
 The respiratory epithelium is the target of a number of invading pathogens, including 
influenza. Once infected, these cells secrete various chemokines and cytokines, which elicit 
an innate antiviral response including the recruitment and activation of inflammatory cells as 
well the production of a number of antiviral mediators to help limit the spread of infection to 
neighboring cells. Of these, type I interferons (IFNs) play an important role in inducing an 
antiviral state in cells through their induction of numerous genes involved in viral defense, 
which helps to limit the infection until other responses are mobilized. Type I IFNs in humans 
consist of IFN-α, β, ε, κ, and ω, of which IFN-α and β have been the most extensively 
studied and are known for their potent antiviral effects (165, 187). The type I IFNs all bind to 
a common receptor, the IFN-α/β receptor (IFNAR) (159, 160, 161), which elicits a signal 
cascade upon activation resulting in the transcription of interferon stimulated genes (ISGs). 
The IFNAR is composed of 2 subunits (IFNAR1 and IFNAR2), which dimerize upon ligand 
binding. These subunits are each associated with a member of the Janus activated kinase 
(JAK) family (36, 80), which are responsible for activating the downstream signaling 
proteins signal transducers and activators of transcription (STATs) (36, 213). Once activated 
the STAT proteins form homodimers or heterodimers and act as transcription factors for a 
variety of ISGs (165, 187).  
Influenza infections in the USA account for approximately 36,000 deaths and over 
100,000 hospitalizations each year, despite large-scale vaccination and antiviral treatments 
(226, 227). Epithelial cells recognize viral pathogens through pattern recognition receptors 
(PRRs), such as TLR3, whose activation leads to the expression of Type I interferons (IFNs) 
and inflammatory cytokines such as regulated upon activation, normal T-cell expressed, and 
secreted (RANTES), interleukin (IL)-6, IL-8, and tumor necrosis factor alpha (TNF-α). 
These cytokines recruit and activate immune cells, which ultimately clear the influenza 
infection.  While these responses are important for fighting off the invading pathogen, they 
are also the cause of much of the resulting morbidity and mortality associated with infection. 
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For this reason these responses must be tightly regulated by the host so that an adequate 
antiviral response can be mounted without causing excessive damage to the host.  
Both influenza infections and type I IFNs have been shown to upregulate TLR3 
expression (67, 74, 103, 135, 228) and virus-induced IFN-β has been proposed to play a role 
in a positive-feedback loop whereby viral infection causes increased TLR3 expression (223). 
Furthermore, studies using TLR3-/- mice have shown that the TLR3-mediated inflammatory 
response has a detrimental contribution to the infected host, and that morbidity and mortality 
was decreased in TLR3-/- mice (103, 245). Taken together, these studies suggest that the 
presence of TLR3 is critical for the induction of antiviral responses, but that expression and 
signaling needs to be tightly regulated.  Additionally, previous results in our laboratory have 
shown that exposure of respiratory epithelial cells to DE prior to infection with influenza 
increases the expression of IFN-β as well as the expression and signaling of TLR3. Given 
these previous findings this study was designed to elucidate the potential role of influenza-
induced IFN-β in the upregulation of TLR3 in respiratory epithelial cells and the 
contribution, if any, of DE exposure to this response. The results shown here demonstrate 
that influenza-induced IFN-β is responsible for the upregulation of TLR3 in influenza 
infected respiratory epithelial cells. Interestingly, IFNAR expression is limited to the 
basolateral side of airway epithelial cells. Exposure to DE affects the integrity of the 
epithelial tight junctional complexes, thereby allowing apically released IFN to access the 
basolateral portion of the cell where the IFNAR is localized in these cells.  
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Materials and Methods 
Cell Culture 
 
A549 cells, a human pulmonary type II epithelial-like cell line were cultured in F12K 
medium plus 10% fetal bovine serum and 1% penicillin and streptomycin (all from 
Invitrogen, Carlsbad, CA). For treatment with IFNs or DEas and stimulation with poly(I:C), 
A549 cells were grown in 6 or 24-well plates.  When the cells reached about 80% confluency 
and about 18-24h before exposure to DEas and stimulation with poly(I:C), the cell culture 
media was exchanged for serum-free F12K plus 1.5µg/ml BSA plus antibiotics. For some 
experiments cells were treated with 1 µM of the tyrosine kinase inhibitor JAK inhibitor I 
(calbiochem, La Jolla, CA), which is specific to the JAK family. Primary human bronchial 
epithelial cells were obtained from healthy nonsmoking adult volunteers by cytologic 
brushing at bronchoscopy. Primary human nasal epithelial cells were obtained from healthy 
nonsmoking adult volunteers by gently stroking the inferior surface of the turbinate several 
times with a Rhino-Probe curette (Arlington Scientific, Arlington, TX), which was inserted 
through an otoscope with a large aperture. The protocols for the acquisition of both primary 
human bronchial and nasal epithelial cells were reviewed by the University of North Carolina 
Institutional Review Board. Both primary human bronchial and nasal epithelial cells were 
expanded to passage 2 in bronchial epithelial growth medium (BEGM, Cambrex Bioscience 
Walkersville, Inc., Walkersville, MD ) and then plated on collagen-coated filter supports with 
a 0.4 µM pore size (Trans-CLR; Costar, Cambridge, MA) and cultured in a 1:1 mixture of 
bronchial epithelial cell basic medium (BEBM) and DMEM-H with SingleQuot supplements 
(Cambrex), bovine pituitary extracts (13mg/ml), bovine serum albumin (BSA, 1.5 µg/ml), 
and nystatin (20 units). Upon confluency, all-trans retinoic acid was added to the medium 
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and air liquid interface (ALI) culture conditions (removal of the apical medium) were created 
to promote differentiation. Mucociliary differentiation was achieved after 18-21 days post-
ALI.  
Transfection with the TLR3 promoter constructs 
 
The wild-type, mutant ISRE, and mutant STAT TLR3 promoter constructs were generous 
gifts from Dr. Rehli (Universtity Hospital, Regensburg, Germany) and were designed as 
previously described (74). A549 cells grown to 60-80% confluence in 24-well tissue culture 
dishes were co-transfected with 250ng of the pTLR3-luc and 25ng of pSV-β-galactosidase 
using  FuGENE 6 transfection reagent (3µl fugene:2µg DNA, Roche).  24 hours after 
transfection cells were then treated.  Luciferase and β-galactosidase activity was determined 
using the Dual Light™ reporter gene assay system (Perkin-Elmer) and an AutoLumat LB953 
luminometer (Berthold Analytical Instruments, Nashua, NH).  Promoter activity was 
estimated as specific luciferase activity (luciferase counts per unit β-galactosidase counts) 
and expressed as fold induction over the respective media control.  
Exposure to aqueous-trapped solution of Diesel Exhaust (DEas) 
DEas was generated as described before (123). Briefly, emissions were taken from a 
Caterpillar diesel engine, model 3304, which was used to power a 113 KW generator. This 
type of engine was chosen because it is used in non-road vehicles, which are significant 
contributors to ambient diesel exhaust levels and because the projected trend for emissions 
from non-road diesel engines is expected to remain at the same level or even increase in the 
future (235). The diesel exhaust emissions from this Caterpillar diesel engine were passed 
through a tubing system with a filter impactor and 2 impinger tubes (containing 100 ml PBS 
each) submerged in an ice bath. Impinger glassware was washed and heated to remove and 
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destroy endotoxin. Of the two impinger tubes, the emissions (at 10 L/min) that entered and 
remained in the first (primary) tube, but not the secondary tube, were utilized for the cell 
exposure studies. Extracts were generated and collected during a one-hour period when the 
engine was under high load (HL). This type of preparation was chosen, because it contains 
both DE particles as well as polar and thus water soluble DE gas-phase components. To 
determine the mass of the emissions retained within the PBS in an impinger tube, an aliquot 
was dried overnight at 56ºC, and corrected for the mass of the PBS contribution (which was 
determined in a similar manner by overnight drying) and dilution with water from the 
exhaust. Aliquots of the DEas were kept at - 20ºC until use. For all cell types used in this 
study, DEas was added 2 hours before infection with influenza or treatment with poly(I:C). 
Specifically, for the differentiated human nasal and bronchial epithelial cells, DEas was 
diluted in 200µl media to achieve 22 or 44µg DEas per cm2 of cell layer and added to the 
apical side. After the 2 hours incubation with DEas, the diluted DEas was removed and 
influenza virus or poly(I:C) was diluted in the same volume of media was added to the apical 
side for 2 hours, after which it was removed to establish ALI culture conditions again. For 
the experiments using A549 cells, DEas was diluted in F12K media plus BSA plus antibiotics 
to achieve 25µg/cm2 and added to the cells. After 2 hours incubation with DEas, poly(I:C) 
was added to the cells. The effects of exposure to DEas on cell viability were assessed by 
analyzing cell culture supernatants for lactate dehydrogenase (LDH) activity using a 
commercially available kit according to the supplier’s instructions (CytoTox 96®, Promega, 
Madison, WI). 
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Infection with influenza or treatment with poly(I:C) or IFNs 
Throughout this study we used influenza A/Bangkok/1/79 (H3N2 serotype) which was 
propagated in 10-day-old embryonated hen’s eggs. The virus was collected in the allantoic 
fluid and titered by 50% tissue culture infectious dose in Madin-Darby canine kidney cells 
and hemagglutination as described before (11). Stock virus was aliquoted and stored at -80oC 
until use. Unless otherwise indicated, for infection of differentiated bronchial or nasal cells 
approximately 3 X105cells were infected with 320 (hemagglutination units) HAU of 
influenza A Bangkok 1/79. Cells were treated with 100 µg/ml of polyinosinic 
acid:polycytidylic acid (poly(I:C)) (Calbiochem; La Jolla, CA) 2 hours after exposure to 
DEas. In some experiments cells were treated with 1 ng/ml of IFN-α, -β, -ω, or -γ (PBL 
Biomedical Laboratories, Piscataway, NJ) by adding them to the culture medium.  
Epithelial Permeability Measurements 
Trans-epithelial resistance (TER) was measured using an epithelial voltohmmeter (EVOM) 
(World Precision Instruments, Sarasota, FL) according to the supplier’s instructions. Trans-
epithelial flux of FITC-labeled dextran was used as another indicator of TER. Briefly, FITC-
labeled dextran was added to the apical side of cells at a concentration of 100 µM. 
Fluorescent intensity of the basolateral media was measured at 0, 2, 4, and 6 hours using a 
fluorescent plate reader (HTS 700) (Perkin-Elmer, Norwalk, CT).  
RT-PCR 
Total RNA was extracted using TRizol (Invitrogen) as per the supplier’s instruction. First-
strand cDNA synthesis and real-time RT-PCR was performed as described previously (86, 
87). The mRNA analyses were performed using commercially available primer/probe sets 
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(inventoried Taqman® Gene Expression Assays) purchased from Applied Biosystems 
(Foster City, CA).  
Immunohistochemistry/Confocal Microscopy 
DE-exposed cells were fixed for analysis of tight junctional protein complexes at 8, 16, and 
24 hours post-exposure. Cells were fixed with acetone for 20 min, washed with TBS and 
blocked with Powerblock (Biogenex, San Ramon, CA) for 1 hr at RT. Following this, cells 
were incubated with primary antibody overnight at 4°C. Primary antibodies: anti-IFNAR2 
used at 1:200 (Santa Cruz, Santa Cruz, CA); anti-ZO1 used at 1:100 (Zymed, San Francisco, 
CA); acetylated α-tubulin used at 1:1000 (Zymed, San Francisco, CA). After incubation with 
primary antibody samples were washed with TBS followed by incubation with secondary 
antibody at 1:200 for 1 hour at RT.  Secondary antibodies: donkey anti-rabbit (fluor 555); 
goat anti-mouse (fluor 405); donkey anti-goat (fluor 488); all from molecular probes 
(Invitrogen). Following incubation with secondary antibody samples were washed with TBS 
and visualized by confocal microscopy using a Nikon C1Si.  
Statistical Analysis 
Data are expressed as means + S.E.M. of at least three separate experiments. Raw data were 
analyzed using one-way ANOVA followed by the Newman-keuls post-hoc test. Data 
expressed as fold induction were analyzed using the Wilcoxon Signed Rank Test, assuming a 
theoretical mean of 1.00 for the control group. A value of p <0.05 was considered to be 
significant. 
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Results 
Soluble mediators released by influenza-infected cells can upregulate TLR3 expression. 
 Previous studies conducted in vitro using human pulmonary epithelial cells and in vivo in 
mice have show that infection with influenza causes increased expression of TLR3 (67, 103). 
However, to our knowledge it has not been shown if TLR3 expression is only upregulated in 
influenza-infected cells or if non-infected cells are also upregulating TLR3 in response to 
mediators released by infected cells. To determine if mediators released by infected cells 
affects TLR3 expression, TLR3 mRNA was quantified in cells, which were treated with 
conditioned media from influenza-infected cells (see diagram in Fig 20A). In this experiment 
primary nasal epithelial cells were first infected with influenza. Basolateral media was 
collected 24 hours post-infections and cells were assessed for viral infection, using RT-PCR 
to quantify HA RNA. The infection-conditioned medium was used to expose new, uninfected 
naïve nasal epithelial cells for 8 hours. TLR3 mRNA expression was then quantified 8 hours 
after placing the cells in the conditioned media using real-time RT-PCR. Figure 20B shows 
that cells cultured in the virus-conditioned media had higher levels of TLR3 mRNA (p=0.06) 
than cells cultured in control-conditioned media. The expression of HA was also quantified 
in these cells to ensure that no residual influenza virus was left in the media and had infected 
these cells, thereby causing the upregulation of TLR3 (data not shown).  
 As stated before, type I IFNs have also been shown to upregulate TLR3 expression (135, 
207, 228). To determine if IFNs had the ability to upregulate TLR3 expression in respiratory 
epithelial cells, A549 cells were treated with 1ng/ml of type I and II IFNs IFN-α, β, ω, and γ 
for 6 hours upon which TLR3 mRNA expression was quantified using real-time RT-PCR. 
All of the type I IFNs significantly upregulated TLR3 mRNA, while IFN-γ caused a non-
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significant increase in the levels of TLR3 mRNA (Fig 21A). Time-course experiments 
showed that the IFN-induced increase in TLR3 mRNA levels was maximal between 4-6 
hours (Fig 21B). Once it was confirmed that type I IFNs could increase TLR3 expression in 
our model, the amount of each type I IFN produced in response to influenza infection was 
quantified 24 hours after infection. Levels of IFN-α, -β, and -ω mRNA were quantified in 
nasal epithelial cells using real-time RT-PCR (Fig 21C). IFN-β mRNA was by far the most 
highly expressed in the cells at this time-point.  
Transcriptional regulation of TLR3 in response to IFN-β treatment 
 Since IFN-β was the predominant IFN expressed in response to infection and an 
increased expression in TLR3 mRNA was observed in cells treated with IFN-β, the 
transcriptional control of TLR3 in response to IFN-β was examined. A549 cells were co-
transfected with the TLR3 promoter (pTLR3) linked to a luciferase reporter gene and pSV-β-
galactosidase prior to treatment. Cells were then stimulated with 1 ng/ml of IFN-β for 6 
hours and specific luciferase activity was determined using β-galactosidase as a normalizing 
factor. As shown if figure 21D, treatment with IFN-β significantly enhanced TLR3 promoter-
reporter activity.   
 The next objective was to confirm the involvement of the IFN signaling pathway in the 
influenza-induced upregulation of TLR3. As stated earlier binding of type I IFNs to the 
IFNAR elicits a signaling cascade involving JAKs. These kinases are responsible for 
phosphorylating and activating STATs, which ultimately leads to transcription of ISGs. A549 
cells were treated with 1µM of a JAK1 inhibitor (see figure 22), or vehicle control prior to 
infection with influenza. TLR3 mRNA levels were then quantified 24 hours post-infection 
using real-time RT-PCR (Fig 23A). Cells treated with the vehicle control showed a 
 82
significant increase in TLR3 mRNA levels in response to infection. However, this response 
was abrogated in cells treated with the JAK1 inhibitor. Cells were also stimulated with IFN-α 
after treatment with the JAK1 inhibitor to ensure that it was the IFN pathway that was being 
blocked. IFN-α increased TLR3 mRNA levels only in cells treated with the vehicle control 
confirming that the type I IFN signaling pathway was in fact inhibited (Fig 23B). Vehicle 
control or JAK inhibitor was then administered in cells co-transfected with the TLR3 
promoter (pTLR3) linked to a luciferase reporter gene and pSV-β-galactosidase to examine 
TLR3 expression at the transcriptional level. As observed before, vehicle-treated cells 
infected with influenza showed significantly increased activation of the TLR3 promoter-
reporter, while this effect was significantly reduced in cells treated with the JAK1 inhibitor 
prior to infection (Fig 23C). Finally, to determine the response elements in the TLR3 
promoter regulating transcription of the gene, cells were transfected with the wild-type 
pTLR3 or a pTLR3 containing a mutation in either the interferon-stimulated response 
element (ISRE) or STAT binding sites of the TLR3 promoter. Following transfection with 
the respective promoter-reporter constructs, cells were then infected with influenza and 
luciferase activity was determined 24 hours post-infection. Figure 23D shows that activation 
of the TLR3 promoter-reporter was significantly reduced in cells containing the pTLR3 with 
the mutated ISRE site. Activation of the TLR3 promoter-reporter was also reduced, albeit not 
significantly, in cells containing the pTLR3 with the mutated STAT site. 
Polarized response of pulmonary epithelial cells to IFN stimulation 
 
 It is well known that the airway epithelium is polarized, with the apical and basolateral 
membranes having different morphological as well as biochemical characteristics and 
functions. Furthermore, studies have shown that certain receptors predominantly localize to 
 83
the basolateral domain of epithelial cells (60, 239) in order to regulate their function. To 
determine if there was a polarized response in airway epithelial cells to IFN-β stimulation, 
TLR3 mRNA levels were quantified in bronchial epithelial cells treated for 6 hours with 1 
ng/ml of IFN-β from either the apical or basolateral side or a combination of both. Figure 
24A shows that only cells receiving basolateral IFN-β stimulation showed increased 
expression of TLR3 mRNA. After observing the polarized response of epithelial cells to IFN-
β, the next objective was to determine the directionality of IFN-β secretion by these cells. 
Levels of IFN-β protein secreted to the apical and basolateral sides were quantified in 
bronchial epithelial cells 24 hours after infection with various doses of influenza. Figure 24B 
shows that bronchial epithelial cells secrete IFN-β at both the apical and basolateral surfaces 
in response to influenza infection in a dose-dependent manner.  
Basolateral localization of the IFNAR in airway epithelium 
 
 Given the polarized response of airway to epithelial cells to IFN-β stimulation it seemed 
likely that the observed responses were due to a polarized expression of the INFAR in these 
cells. To test this hypothesis human tracheal tissue was immunohistochemically stained for 
IFNAR expression. As expected, IFNAR staining was predominantly localized to the 
basolateral portion of the tracheal epithelium (Fig 25A). To confirm these results in our cell 
model bronchial epithelial cells were also immunohistochemically stained for INFAR 
expression and visualized using confocal microscopy. Figures 25B and 25C show that the 
same expression pattern observed in the trachea is also seen in bronchial epithelial cells.  
Diesel exhaust enhances epithelial cell permeability 
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 Previous work in our laboratory has demonstrated that exposure of respiratory epithelial 
cells to DE prior to infection with influenza causes an increase in TLR3 expression (31, 
figures 3 and 4). However, the mechanism whereby an air pollutant, such as DE, can alter the 
response to a respiratory viral infection remains unknown. The data showing the involvement 
of the type I IFN signaling pathway in the influenza-induced upregulation of TLR3 
expression, along with the polarization of the IFNAR led us to investigate the effects of DE 
on the permeability of the epithelium, which could allow access of apically released 
mediators to receptors on the basolateral portion of the cell. In fact previous studies have 
shown that air pollutants such as ozone and cigarette smoke can increase airway epithelial 
permeability through an effect on epithelial cell tight junctions (15, 18, 20, 62, 152). To 
examine if DE could exert similar effects on epithelial permeability bronchial epithelial cells 
were treated with 22 or 44 µg/cm2 of DE for 2 hours followed by the addition of 
fluorescently labeled dextran to the apical surface. Trans-epithelial flux was determined by 
measuring fluorescent intensity of the basolateral media at 0, 2, 4, and 6 hours after the 
addition of the fluorescent-labeled dextran (Fig 26A). The fluorescent intensity at 6 hours 
was significantly greater in the basolateral media of cells treated with 44 µg/cm2 of DE 
compared with untreated cells, indicating that exposure to DE increased trans-epithelial flux. 
Trans-epithelial electrical resistance was also reduced in cells exposed to 44 µg/cm2 of DE 
(data not shown). To confirm and expand upon these results the effect of DE exposure on the 
disruption of tight junctional complexes was examined in bronchial epithelial cells using 
immunohistochemical staining for ZO-1. Cells were treated with 44 µg/cm2 of DE for 2 
hours and then fixed and immunohistochemically stained for ZO-1, a protein present in the 
tight junctional complexes of epithelial cells (81, 208), 16 hours after DE exposure. Cells 
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were then visualized using confocal microscopy. Figure 26B shows that disruption of tight 
junctional complex integrity, denoted by a thickening and interruption of the fluorescent 
staining, was observed in DE-exposed cells.  
 Effect of DE on IFNAR expression 
 Given the previous results, in which increased TLR3 expression was observed in 
respiratory epithelial cells exposed to DE prior to infection with influenza, the effect of DE 
exposure on the expression of the IFNAR was examined. Levels of IFNAR mRNA were 
quantified 24 hours post-infection in bronchial epithelial cells exposed to 44 µg/cm2 of DE 
prior to infection with influenza. Figure 27A shows that cells exposed to DE prior to 
infection had significantly greater levels of IFNAR mRNA. These experiments were repeated 
in A549 cells exposed to 25 µg/cm2 of DE prior to stimulation with poly(I:C). Figure 27B 
shows that expression of IFNAR mRNA is significantly increased in cells exposed to DE 
prior to stimulation with poly(I:C).  
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Discussion 
 Previous studies have shown that infection with influenza results in enhanced TLR3 
expression (67, 103), but the mechanism whereby this upregulation occurs had not been 
completely elucidated. Based on previous studies it was hypothesized that influenza-induced 
IFN production played a role in the upregulation of TLR3 and that the enhancement of this 
response by DE involved effects on epithelial permeability. The results of this study show 
that the influenza-induced upregulation of TLR3 in respiratory epithelial cells is dependent 
on type I IFNs, which can act in a paracrine manner to induce TLR3 expression in 
neighboring cells. Furthermore, under normal conditions, the receptor for type I IFNs, the 
IFNAR, is localized on the basolateral membrane of airway epithelial cells and exposure to 
DE can increase the expression of the IFNAR as well as the access of apically secreted 
mediators to this receptor. Together these data provide a mechanism whereby the host can 
enhance the recognition of and response to influenza infections and how exposure to a 
common air pollutant like DE can alter this response.  
 Despite previous observations that influenza infection upregulates TLR3 expression, it 
was unknown if this was a direct effect of the infection or induced by mediators secreted by 
infected cells. Given the function of TLR3, which is to sense dsRNA produced during the 
viral replication cycle and to elicit signaling ultimately resulting in the production of pro-
inflammatory cytokines and type I IFNs, it seemed the more effective response would be an 
upregulation of TLR3 not only in infected cells, but also in cells that have yet to be infected. 
This would provide a more robust response if the infection continued to spread and 
neighboring cells became infected. Given this reasoning the ability of influenza-infected cells 
to signal an upregulation of TLR3 in neighboring cells was examined. Nasal epithelial cells, 
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which were infected with influenza, did in fact secrete mediators that caused an upregulation 
of TLR3 in uninfected cells. This response was not due to residual virus left in the cellular 
media from infected cells, which was confirmed by the absence of HA RNA in the 
uninfected cells. The fact that mediators released by epithelial cells in response to influenza 
infection can act in a paracrine manner to ‘prime’ neighboring cells amplifies innate defense 
responses against viral infection. 
 Previous studies have also demonstrated that both IFN-α and IFN-β have the ability to 
stimulate TLR3 expression (135, 228). To confirm and expand upon these findings the ability 
of the type I IFNs α, β, and ω as well as the type II IFN γ, to stimulate TLR3 expression in 
A549 cells were examined. Similar to previous results treatment with IFN-α and -β resulted 
in a significant increase in TLR3 mRNA expression. Interestingly, IFN-ω was also able to 
significantly induce TLR3 mRNA expression indicating this effect is not specific to just IFN-
α and -β, but that other type I IFNs exert a similar effect. This implies the involvement of the 
type I IFN signaling pathway in this response. IFN-γ was not able to induce a significant 
induction of TLR3 expression at the levels used in our experiments. It may be that higher 
levels of IFN-γ are needed to stimulate TLR3 expression in these cells, or the induction of 
TLR3 may occur at a later time-point than the ones examined in this study. Since IFN-γ plays 
a more important role in cell-mediated immunity through its activation of NK cells and 
macrophages, and its production is actually stimulated by type I IFNs it might not be 
necessary for INF-γ to exert this type of response in respiratory epithelial cells. 
 Given the ability of all of the type I IFNs tested to upregulate TLR3 expression it was 
necessary to determine which type I IFNs were produced by epithelial cells in response to 
influenza infection. The mRNA expression of IFN-α, -β, and -ω were examined 24 hours 
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post-infection. The mRNA levels of IFN-β were by far the highest observed at this time-
point. Given these data, we focused on IFN-β for the remainder of the TLR3 expression 
studies. Transcriptional regulation of TLR3 was then examined using a variety of different 
TLR3 promoter constructs. Treatment with IFN-β caused significant TLR3 promoter activity 
indicating that type I IFNs enhance TLR3 expression at the transcriptional level. Next the 
transcriptional regulation of TLR3 and the involvement of the type I IFN pathway in this 
response were examined. Inhibition of the JAK/STAT pathway, using a JAK1 inhibitor, 
confirmed that type I IFN signaling was indeed necessary for both increased TLR3 promoter 
activation and TLR3 mRNA expression. These data indicate that type I IFN binding to the 
IFNAR activates a signaling cascade, which ultimately results in increased TLR3 mRNA 
expression. Next transcription factor binding sites within the TLR3 promoter were examined 
for their role in TLR3 transcriptional activity following IFN-β stimulation. The ISRE, but not 
the STAT binding site, was required for TLR3 promoter-reporter activity. This was not 
surprising considering the ISRE is found in the promoters of numerous interferon-stimulated 
genes (37, 105, 195). Activation of the pTLR3 was also reduced, although not significantly, 
in the promoter containing the mutated STAT site indicating that this site may not be 
essential for activation, but may be required for maximum response to be elicited.  
 The involvement of type I IFNs in the influenza-induced upregulation of TLR3 is not 
surprising considering the role of these cytokines is to induce the expression of genes 
involved in antiviral defenses. In order for the type I IFNs to exert their effects they must 
bind to IFNAR, which then activates a signaling cascade that ultimately results in the 
expression of various interferon-stimulated genes. The regulation of certain receptors’ ligand 
binding and subsequent activation in epithelial cells is achieved through a polarized 
 89
localization of these receptors (60, 239). An increase in TLR3 expression was only observed 
in cells stimulated with IFN-β from the basolateral side suggesting a similar polarization of 
IFNAR localization in airway epithelial cells. Immunohistochemical staining confirmed the 
basolateral localization of the IFNAR in the airway epithelium. A possible explanation for 
this polarized localization is that under normal circumstances, epithelial cells may only 
receive IFN stimulation from the basolateral side in vivo. Dendritic cells, which produce a 
large amount of type I IFNs after viral infections, usually reside on the basolateral side of the 
epithelium. Alternatively, sequestration of the IFNAR to the basolateral membrane may 
serve to limit the amount of stimulation these receptors receive or it may be a way of 
regulating their activation. Given their localization, IFNs released to the apical side of 
epithelial cells would be unable to act on these receptors under basal conditions. However, 
under certain circumstances epithelial cells may increase apical expression of the IFNAR or 
allow access of apically released IFNs to the basolateral side of the cell through changes in 
cell permeability. A similar regulatory mechanism is employed by airway epithelial cells to 
control binding of the growth factor heregulin to its receptors (239). Under normal 
conditions, heregulin, which is located on the apical surface, cannot bind to its receptors, 
which are located on the basolateral membrane. However, when the integrity of the 
epithelium is compromised heregulin can bind its receptors on the basolateral portion of the 
cell and promotes repair of the damaged epithelium. Thus, the cell is able to control receptor 
ligand binding so that signaling is elicited only when necessary. In the case of the INFAR 
and type I IFNs epithelial cells may prevent excess stimulation through sequestration of 
receptor and ligand, but when epithelial integrity is compromised, such as would be the case 
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during more severe infections, there may be a need for enhanced antiviral responses to 
prevent viruses from permeating the epithelial barrier.  
 Previous work in our laboratory has demonstrated that exposure of respiratory epithelial 
cells to DE prior to infection with influenza causes an increase in TLR3 expression (31). 
However, the complete mechanism whereby DE caused an enhancement of the influenza-
induced upregulation of TLR3 remains unknown. In addition, studies by other groups have 
shown that exposure of the airway epithelium to air pollutants such as cigarette smoke and 
ozone can increase permeability by affecting tight junctions (15, 18, 20, 62, 152). Given the 
polarization of the IFNAR and it’s involvement in the influenza-induced upregulation it 
seemed plausible that DE’s enhancement of this response could in part be mediated by a DE-
induced increase in the permeability of the epithelium. Exposure of epithelial cells to DE did 
in fact reduce trans-epithelial resistance and increased trans-epithelial flux of the epithelium. 
To elucidate the mechanism behind this response, the effects of DE on the opening of 
epithelial tight junctions were examined. Immunohistochemical staining for ZO-1, a protein 
in tight junctional complexes of airway epithelial cells, confirmed our assumptions that 
exposure to DE caused a disruption of epithelial cell tight junctional complex integrity and 
thus increased permeability of the epithelium. These data provide a plausible explanation for 
our previously observed effects, demonstrating that exposure to DE increases influenza-
induced effects on TLR3 expression in response to influenza infection. Specifically, 
increased permeability of the airway epithelium would allow apically released IFNs to access 
the basolateral portion of the cell where the IFNAR is located. Increased activation of the 
IFNAR would then result in increased TLR3 expression as was originally observed in 
epithelial cells exposed to DE prior to infection (see figures 3 and 4). The effect of DE on the 
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expression of the IFNAR itself was also examined. Surprisingly, expression of IFNAR was 
also increased in cells exposed to DE prior to infection with influenza. This effect would 
further amplify the upregulation of TLR3. DE exposure not only results in increased access 
of IFNs the INFAR, but also increased the expression of the IFNAR thereby providing 
additional receptors for the IFNs to bind. This enhancement of a tightly regulated cellular 
mechanism could potentially have a detrimental impact on the host. 
 The data presented here demonstrate that mediators secreted by airway epithelial cells in 
response to influenza infection can act in a paracrine manner to upregulate TLR3 expression 
in uninfected cells. Additionally, type I IFNs can increase the transcription and mRNA 
expression of TLR3 through signaling elicited upon their binding to the IFNAR, which is 
localized on the basolateral portion of airway epithelial cells. Furthermore, exposure to DE 
can enhance this response through its effects on tight junctional complexes, resulting in 
increased access to IFNAR, and enhanced IFNAR expression. Taken together, these results 
provide a further understanding of the epithelial innate antiviral responses and how exposure 
to air pollutants can alter these responses.  
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Figure 20.  Effect of soluble mediators on TLR3 expression. 
a) Schematic of experimental design. b) Nasal epithelial cells were left untreated or 
infected with ~320 HAU/105 cells of Influenza A. 24 hrs after infection media from 
cells was taken and used to culture new cells. TLR3 mRNA was quantified 8 hrs after 
the 2nd set of cells was cultured in the conditioned media by real-time RT-PCR. 
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Figure 21. Effect of IFNs on TLR3 expression and promoter activationa) A549 cells were 
treated with 1ng/ml of IFNs and TLR3 mRNA expression was quantified 6 hrs after 
treatment by real-time RT-PCR. b) A549 cells were treated with 1ng/ml of IFN-β and 
TLR3 mRNA levels were quantified 1, 2, 4, and 6 hrs after treatment by real-time RT-
PCR. c) Nasal epithelial cells were treated with ~640 HAU/105 cells and IFN levels were 
quantified 24 hrs after infection. d) A549 cells were co-transfected with the TLR3 
promoter (pTLR3) linked to a luciferase reporter gene and pSV-β-galactosidase 24 hrs 
prior to treatment. Cells were then stimulated with 1 ng/ml of IFN-β for 6 hours and 
specific luciferase activity was determined using β-galactosidase as a normalizing factor 
and data expressed as fold induction over control. *significantly different from control; 
p<0.05 
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Figure 23. Effect of JAK inhibition on influenza-induced TLR3 mRNA expression and 
promoter activation.a) A549 cells were treated with 1µM of a JAK1 inhibitor, or vehicle 
control (DMSO) prior to infection with ~320HAU/105 cells of influenza. TLR3 mRNA 
levels were then quantified 24 hours post-infection using real-time RT-PCR. b) A549 cells 
were treated with 1µM of a JAK1 inhibitor, or vehicle control prior to treatment with 1ng/ml 
of IFN-α. TLR3 mRNA levels were then quantified using real-time RT-PCR. c+d) A549 
cells were co-transfected with the TLR3 promoter (pTLR3) linked to a luciferase reporter 
gene or a pTLR3 with mutations in the ISRE or STAT binding sites,  and pSV-β-
galactosidase 24 hrs prior to treatment. Cells were then infected with ~320HAU/105 cells of 
influenza. Specific luciferase activity was determined 24 hrs post-infection using β-
galactosidase as a normalizing factor. Values for a, c, and d are expressed as fold induction 
over uninfected control. *significantly different from control, @significantly different from 
uninhibited, #significantly different from WT; p<0.05 
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Figure 22. Schematic of JAK Inhibition
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Figure 24. Effect of IFN-β on TLR3 expression 
a) Bronchial epithelial cells were treated from the apical and basolateral sides with 1ng/ml 
of IFN-β. TLR3 mRNA was quantified 6 hrs after treatment using real-time RT-PCR. 
*significantly different from control, p<0.05 b) Levels of IFN-β protein were quantified by 
ELISA in apical washes and basolateral media of bronchial epithelial cells infected with 
varying doses of influenza at 24 hours post-infection.  
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Figure 25. Localization of IFNAR 
a) Human trachea immunohistochemically stained for IFNAR (top) and 
acetylated α-tubulin (bottom). b) Differentiated bronchial epithelial 
cells immunohistochemically stained for IFNAR (top). H+E staining of 
bronchial epithelial cells (bottom). c) Differentiated bronchial epithelial 
cells immunohistochemically co-stained for IFNAR (red) and acetylated 
α-tubulin (green). Staining was visualized by confocal microscopy.  
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 Figure 26. Effect of DE on epithelial cell tight junctional complexes 
a) Differentiated bronchial epithelial cells were treated with 22 or 44 µg/cm2 of DE for 2 
hours followed by the addition of fluorescently labeled dextran to the apical surface. 
Trans-epithelial flux was determined by measuring fluorescent intensity of the basolateral 
media at 0, 2, 4, and 6 hrs after the addition of the fluorescent-labeled dextran. Data is 
expressed as % fluorescence of total amount added. *significantly greater than control, 
p<0.05. b) Differentiated bronchial epithelial cells were treated with 44 µg/cm2 of DE for 
8 hours. Cells were then immunohistochemically stained for ZO-1 and visualized by 
confocal microscopy.  
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Figure 27. Effect of DE on IFNAR expression 
IFNAR mRNA was quantified 24 hrs after infection with influenza or stimulation with 
poly(I:C) using real-time RT-PCR. a) Differentiated bronchial epithelial cells were 
treated with 44 µg/cm2 of DE for 2 hours prior to infection with ~320 HAU/105 cells of 
influenza A. Data expressed as fold induction over influenza infected samples. 
*significantly different from non-DE exposed, p<0.05. b) A549 cells were treated with 
25 µg/cm2 of DE for 2 hours prior to stimulation with 100 µg/ml of poly(I:C). 
*significantly different from control, p<0.05.  
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Chapter 5 
Overall Discussion 
 The data presented here demonstrate how exposure to a common air pollutant, like diesel 
exhaust can enhance the susceptibility and response to a respiratory viral infection through an 
alteration of the host’s innate immune responses. Exposure to DE enhances a tightly 
controlled positive-feedback loop in pulmonary epithelial cells and results in an increase in 
the expression and function of TLR3. Since TLR3 is largely responsible for the inflammatory 
response to influenza (3, 67, 103, 104), it is likely that increased TLR3 expression will result 
in increased inflammation during an influenza infection. Additionally, studies using TLR3-/- 
mice have shown that the TLR3-mediated inflammatory response has a detrimental 
contribution to the infected host and that morbidity and mortality are reduced in mice lacking 
TLR3 (103, 245). Taken together, these data indicate that the DE-induced increase in TLR3 
expression and signaling are likely to have a detrimental effect on an infected host. 
 Increased susceptibility and responses to influenza infections were observed both in vitro 
and in vivo, which provides compelling evidence that the same effects observed in the 
laboratory may also be occurring in humans. Therefore, it is possible that individuals 
exposed to DE are more susceptible to influenza virus infections and that the resulting 
infection will present with increased inflammation and morbidity in certain sub-populations, 
such as children and the elderly. For these reasons, the data presented here could have 
important public health implications for all of the areas in which exposure to DE is a 
concern. 
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Figure 28  Overall hypothesis of the effects of DE on the influenza-induced upregulation 
of TLR3  
 DE has become a concern in many areas since it can account for a significant percentage 
of air pollutants generated by motor vehicles (42, 234, 235) and epidemiological data and 
experimental studies suggest that DE is a major contributor to adverse health effects 
associated with exposure to particulate air pollutants (235, 249). A majority of the diesel PM 
emissions are produced by off-road and heavy on-road vehicles (233), which is significant 
because off-road diesel engines emit about 2 times the amount of PM as on-road vehicles, 
making them a serious concern for PM-induced health effects (23). In fact, one study showed 
that average personal exposure to PM was 9 times higher for those working around forklift 
powered by diesel compared to those working around forklifts powered by other fuels (262). 
Other occupations for which, an increased exposure to DEPs have been shown include 
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mechanics, truck drivers, and mine workers, where concentrations can range from 25 µg/m3 
to 1mg/m3  (175, 192, 262). These data indicate that a particularly susceptible population to 
the DE-induced effects on the susceptibility and response to viral infection would be those 
who receive occupational exposures to DE.  
 Individuals who are occupationally exposed to higher concentrations of DE do not 
represent the only sub-population for which, an increased susceptibility to the effects of DE 
exposure exist. Those who have pre-existing allergic and pulmonary diseases are also at 
higher risk, not because they are exposed to higher concentrations of DE, but because their 
condition renders them more susceptible. As mentioned earlier, studies have shown that DE 
increases cellular responsiveness to histamine (75, 100) and acts as an adjuvant to IgE 
production (44, 55, 143, 149). DEPs have also been shown to adsorb allergens, which could 
cause a further enhancement of the DE-mediated responses (153). Additionally, studies have 
demonstrated that patients with obstructed airways show increased lung deposition of PM 
(137, 179, 194) and that a 30% decrease in airway cross-sectional area results in 
approximately a 100% increase in particle deposition in the bifurcating airways (184, 99). 
Thus, DE particle deposition may be significantly higher in the lungs of individuals with 
obstructed or restricted airways. 
 The enhanced susceptibility to respiratory viral infections caused by exposure to DE 
could have even more serious implications for individuals with pre-existing pulmonary 
conditions. Several studies have shown that respiratory viral infections are associated with 
asthma exacerbations in both children and adults and that there may be a synergistic effect 
when individuals are infected with a respiratory virus and exposed to certain allergens (63, 
92, 98, 147, 170, 246). Furthermore, another study showed that exposure to air pollution 
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increased the severity of virus-induced asthma in children (29). In addition to asthma, 
enhanced frequency and morbidity of chronic obstructive pulmonary disease (COPD) has 
been associated with respiratory viral infections, including influenza (157, 172, 199, 198). 
Therefore, DE-induced modifications of the susceptibility to respiratory infections would be 
particularly detrimental to these individuals.  
 Two other susceptible populations that may be affected by DE exposure are children and 
the elderly. Individuals over 65 years old are more likely to die from influenza infections and 
along with those under 2 years are more likely to be hospitalized due to influenza infection 
(193, 227). Due to their age these 2 groups are at a higher risk for adverse health effects 
associated with viral infection or exposure to air pollutants. In fact, numerous studies have 
demonstrated that these 2 populations show increased susceptibility and response to 
respiratory infections, as well as other adverse health effects, upon exposure to various air 
pollutants, including PM (29, 46, 82, 117, 136, 140,  167, 196, 197, 251). Altered 
susceptibility or immunity to viral infections in these 2 groups could potentially result in 
severe health effects. Children usually spend more time outdoors than adults so they may be 
exposed for a longer duration, which is of particular concern for those children living in close 
proximity to freeways or other sources of air pollutants. 
 In addition to DE, children are also particularly susceptible to the effects of other 
particulate air pollutants, such as environmental tobacco smoke (ETS) and woodsmoke or 
other biomass fuel emissions. These pollutants are similar to DE in the respect that they 
consist of particulates having chemicals, such as polyaromatic hydrocarbons (PAHs), 
adsorbed onto them. PAHs result from the incomplete combustion of organic materials and 
are thought to be responsible for some DE-induced effects (28). Epidemiological studies 
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have shown that children exposed to woodsmoke or PM from other biomass fuels are at 
greater risk for becoming infected with a respiratory virus as well as dying from the 
subsequent infection (5, 33, 40, 51, 91, 101, 138, 141, 173). Studies have also shown that 
exposure to ETS is associated with an increased frequency and severity of respiratory viral 
infections in children, yet the mechanisms behind these effects are still largely unknown (19, 
66, 68, 77, 118). The mechanisms whereby DE can alter the response to influenza infection 
as shown here may provide insight into the effects elicited by other oxidant gaseous and 
particulate pollutants.  
 While extensive epidemiological and experimental human studies will be needed to 
elucidate how factors such as length and frequency of exposure will affect the host immune 
response to respiratory viral infections, the mechanistic aspects can be efficiently studied 
using in vitro techniques, which allow for the control of many confounding factors present in 
other types of studies. In addition to demonstrating the effects of DE on the innate immune 
response to influenza infections, this work has also begun to elucidate the underlying cellular 
and molecular mechanisms driving these effects. The results presented here provide insight 
into the cellular mechanisms whereby exposure to an air pollutant such as DE can modulate 
the host response to respiratory viral infection. Pulmonary epithelial cells are the primary 
targets of both air pollutants and a number of respiratory viruses, and employ similar 
responses and defenses upon exposure and infection. Therefore, the mechanisms described 
herein provide a model of cellular responses to environmental insults and how these 
influence innate immune responses, particularly at the cellular level.  
 Previous findings in our laboratory as well as others’ have shown that exposure to DE 
enhances the susceptibility to influenza infections both in vitro and in vivo (28, 69, 85). 
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However, the mechanism whereby exposure to DE increases the susceptibility to infection is 
still not completely understood. Various explanations have been proposed, such as decreased 
antiviral and immune mediators, altered function or reduced expression of antiviral proteins, 
or even oxidative stress, and there is conflicting evidence in the literature to support or 
dispute each one. Due to the differences in exposure regimens as well as other experimental 
parameters, such as animal, virus strains, or timepoints, the differences in observed effects 
and proposed mechanisms are not surprising. Despite certain differences in their findings and 
experimental protocols, the overall observation that exposure to DE enhances the 
susceptibility to respiratory viral infections is consistent. It is the mechanism behind this 
effect that is still questionable and a further understanding of how this effect is occurring will 
provide valuable information. 
 The most plausible explanation seems to be that exposure to DE results in a suppression 
of the host’s innate antiviral defenses. The host employs IFN-dependent responses, which 
involve various antiviral proteins mainly involved in inhibiting viral replication, as well as 
IFN-independent responses such as collectins and defensins, which play a role in virus 
binding and phagocytosis (see chapter 1). However, with a variety of antiviral defenses 
involved in the innate immune response and differences between cell types and species as 
well as differences in which responses are essential for different types of infections, there are 
various ways whereby DE may exert its effects. One aspect of the innate antiviral defense 
system that DE may alter is the expression or function of surfactant proteins (SPs). These 
proteins contribute to innate antiviral defenses through their ability to bind and neutralize 
virus (13, 72) and previous studies have shown that SP-A and SP-D play an important role in 
the uptake and clearance of influenza as well as other respiratory viruses such as respiratory 
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syncytial virus (RSV) and adenovirus (71, 70, 108, 109, 110, 113). Therefore, these results 
indicate that a decrease in expression or alteration of function of SP-A or SP-D would render 
the host more susceptible to respiratory virus infection. In fact, findings in our laboratory as 
well as others’ have shown that exposure of mice to DE results in decreased expression of 
SP-A and SP-D, which is associated with enhanced susceptibility to respiratory virus 
infection (71, see figures 18 and 19 ). 
 The decreased expression of SP-A and SP-D caused by exposure to DE may also have 
other effects not relating to viral infection. In addition to their roles in antiviral and 
antibacterial responses, SPs have also been shown to play a role in allergic responses and 
other pulmonary diseases. Several experimental studies have shown that both SP-A and SP-D 
can bind and aggregate many different allergens, inhibit IgE binding to these allergens, as 
well as prevent allergen-dependent histamine release and mast cell degranulation (50, 121, 
126, 243, 244).  Furthermore, studies have shown that SPs can reduce airway 
hyperresponsiveness, and mice deficient for SP-A or SP-D were more susceptible to 
pulmonary hypersensitivity after exposure to allergen (122, 206, 217). Therefore, a decrease 
in SP-A or SP-D expression caused by exposure to DE could lead to increased frequency or 
exacerbations of allergic responses. Experimental studies have demonstrated that mice 
deficient for SP-A or SP-D show pulmonary changes consistent with emphysema (73). 
Finally, one study has shown that SP-A was deleted from the majority of cancer tissues in 
patients with non-small cell lung cancer and deletion in tumors or adjacent bronchial tissue 
was associated with increased risk of disease relapse (88). Taken together, these studies 
demonstrate how decreased surfactant protein expression not only has an impact on the host 
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defense against invading pathogens, but also on other aspects of host immunity as well as 
other pulmonary disease states.  
 Another possible driving force for the enhanced susceptibility to infection, as well as 
increased inflammation, caused by exposure to DE is oxidative stress. Exposure to DE has 
been shown to induce oxidative stress and can result in the production of free radicals, which 
can have damaging effects on the lung (9, 41, 85). The epithelial lining fluid (ELF) of the 
lung contains various antioxidants such as mucins, glutathione (GSH), ascorbate, uric acid, 
α-tocopherol, as well as other molecules that protect the lung from oxidative damage and 
there is evidence that oxidant pollutants react with some of these antioxidant molecules (97). 
Since epithelial cells lining the respiratory tract are the primary targets for invading 
pathogens as well as air pollutants, there may be a connection between the oxidative state of 
these cells and their susceptibility and response to viral infection. In fact, one study observed 
a decreased susceptibility to influenza infections in mice supplemented with GSH (21). 
Furthermore, studies conducted in our laboratory support this notion and have shown that 
pre-treatment of respiratory epithelial cells with GSH reverses the DE-induced enhancement 
of influenza infections (85). Therefore, it seems that oxidative state is an important 
determinate of the ability of the virus to infect the host cell. In addition to enhanced 
susceptibility, oxidative stress may also contribute the enhanced inflammatory response 
caused by exposure to DE. Generally, antioxidants have been suggested to be protective 
against respiratory virus-induced inflammation and injury. Specifically, studies by Beck et al. 
showed that the pathogenesis of a viral infection was exacerbated in mice that had a 
nutritionally-induced state of oxidative stress (10). Another study showed that transgenic 
mice with enhanced expression of extracellular superoxide dismutase showed less lung injury 
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and inflammation after infection with influenza compared with infected wild-type mice 
(218). Further examination will be necessary to elucidate the exact contribution of oxidative 
stress to viral infection and the underlying mechanisms that may be ultimately responsible 
for the observed effects.   
 Evidence presented here suggests that the major driving force behind the influenza-
induced upregulation of TLR3 is a positive-feedback loop involving type I IFNs.  Previous 
studies in our laboratory as well as others’ have shown that type I IFNs can increase TLR3 
expression (135, 228, see figure 21). In addition, exposure to DE prior to influenza infection 
results in significantly greater levels of IFN-β both in vitro and in vivo (see figures 7 and 17). 
The mechanism behind the enhanced IFN-β response most likely involves other DE- or 
virus-induced effects besides the increase in TLR3 expression and signaling. Previous studies 
have shown that exposure to DE can activate the PI3k/Akt signaling pathway, which plays a 
role in IFN-β transcription (31, 120, 190, see figure 8). This activation is most likely 
mediated by ROS, since the PI3k/Akt pathway is involved in oxidative stress signaling and 
ROS can react with several components of this pathway at multiple levels (8). An additional 
source of IFN-β may also be provided by RIG-I. Previous studies have shown that RIG-I 
signaling results in the production of IFN-β in response to influenza infection (104, 129, 
162). Additionally, exposure to certain types of DE prior to stimulation with dsRNA can 
increase the expression of RIG-I (see figure 9).  Based on studies demonstrating that RIG-
dependent IFN-β production is evident as early as 2 hours post-infection (94, 95, 102), one 
possibility is that RIG-I provides the early stimulation for TLR3 transcription and increased 
expression caused by influenza infection. Furthermore, DE may enhance or contribute to this 
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effect through an activation of the PI3k/Akt pathway, which has been suggested to play a role 
in IFN-β production (31, 120, 190, see figure 8).  
 Another way in which DE may contribute to the IFN-induced upregulation of TLR3 is 
through disruption of epithelial tight junctions resulting in increased permeability of the 
epithelium (see figure 26). Increased permeability of the epithelium would allow apically 
released IFNs to access the basolateral portion of epithelial cells where the IFNAR is located, 
resulting in increased signaling and upregulation of TLR3. In addition to increasing the 
permeability of the epithelium, exposure to DE also resulted in enhanced expression of the 
IFNAR (see figure 27), which would further enhance the effect of IFN-β on the expression of 
TLR3.  
 Disruption of epithelial cell tight junctions caused by exposure to DE leading to increased 
permeability of the epithelium could impact the activation of other receptors, which are also 
located on the basolateral portion of epithelial cells. The coxsackievirus and adenovirus 
receptor (CAR) mediates infection by group B coxsackieviruses and subgroup C 
adenoviruses (14, 229). The CAR has been shown to be localized on the basolateral portion 
of polarized airway epithelial cells, thereby limiting the infectivity of these viruses (163, 241, 
261). However, exposure to DE or other air pollutants which disrupt epithelial cell tight 
junctions, such as ozone or ETS (15, 18, 20, 62, 152), could enhance the susceptibility to 
infection by coxsackieviruses or adenoviruses by allowing increased access to the basolateral 
portion of airway epithelial cells where the CAR is located. The epithelial growth factor 
receptors (EGFR) have also been shown to be localized to the basolateral portion of airway 
epithelial cells while their ligand is located on the apical surface (239). This arrangement 
assures that receptor activation only occurs when epithelial integrity is disrupted. However, 
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disruption of the epithelial tight junctional complexes by DE or other pollutants may allow 
for unnecessary activation of the EGFR leading to increased cell proliferation where it is not 
needed. Yet another receptor which has been shown to be localized to the basolateral portion 
of epithelial cells is the IL-6 receptor (128). Similar to the IFNAR, increased access of IL-6 
to its receptor resulting from an enhanced permeability of the epithelium, could lead to an 
exacerbation of the inflammatory response leading to increased morbidity of respiratory viral 
infections.  This is one way in which exposure to DE may increase the viral inflammatory 
response in a TLR3-independent manner. As stated earlier, ETS and ozone have also been 
shown to increase the permeability of the epithelium (15, 18, 20, 62, 152), therefore exposure 
to either of these agents may have similar consequences as DE exposure.  
 The studies mentioned within this dissertation demonstrate how exposure to a common 
pollutant can alter host immunity to respiratory viral infections. Considering that the most 
common form of illness in the U.S. and Europe is respiratory allergies and infections, which 
account for more missed work as well as school days than any other disease, it is important to 
understand the associations between, the potential effects of, and the mechanisms involved in 
air pollution-induced exacerbation of respiratory infections. As more studies are conducted 
we will continue to improve our understanding of how these effects are elicited and who, if 
anyone, is most susceptible. An important challenge for the future will be to further our 
understanding of cellular and molecular mechanisms mediating pollutant-induced effects on 
the susceptibility to viral infections and potential therapeutic strategies to overcome these 
effects.  
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